≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback

Other and unspecified abdominal hernia

DOID EFO Endpoint Browser PheWeb

K11_OTHABDHER

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Hospital discharge: ICD-10 — K45, K46
  • Hospital discharge: ICD-9 — 551[8-9]|552[8-9]|553[8-9]
  • Hospital discharge: ICD-8 — 551[8-9]
  • Cause of death: ICD-10 — K45, K46
  • Cause of death: ICD-9 — 551[8-9]|552[8-9]|553[8-9]
  • Cause of death: ICD-8 — 551[8-9]

2 out of 7 registries used, show all original rules.

1494

4. Check minimum number of events

None

1494

5. Include endpoints

None

1494

6. Filter based on genotype QC (FinnGen only)

1494

Control definitions (FinnGen only)

Control exclude
K11_HERNIA

Extra metadata

Level in the ICD hierarchy
3
First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

Key figures

All Female Male
Number of individuals
Whole population 11376 6164 5110
Only index persons 9484 5301 4183
Unadjusted period prevalence (%)
Whole population 0.16 0.18 0.14
Only index persons 0.18 0.19 0.16
Median age at first event (years)
Whole population 59.82 61.30 57.99
Only index persons 57.88 59.29 56.11

-FinnGen-

Key figures

All Female Male
Number of individuals 1494 838 656
Unadjusted period prevalence (%) 0.29 0.29 0.29
Median age at first event (years) 59.35 57.92 61.18

-FinRegistry-

Age distribution of first events

-FinnGen-

Age distribution of first events

-FinRegistry-

Year distribution of first events

-FinnGen-

Year distribution of first events

-FinRegistry-

Cumulative Incidence Function

-FinnGen-

Cumulative Incidence Function

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1349
Matched controls
13491
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
K46.9
ICD-10 Finland
Unspecified abdominal hernia without obstruction or gangrene
1090.3
323.0
390
5
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
385.6
323.0
442
17
K45.8
ICD-10 Finland
Other specified abdominal hernia without obstruction or gangrene
7349.0
323.0
492
*
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
1205.0
215.7
205
*
K45.0
ICD-10 Finland
Other specified abdominal hernia with obstruction, without gangrene
+∞
174.9
164
*
K40.9
ICD-10 Finland
Unilateral or unspecified inguinal hernia, without obstruction or gangrene
80.2
172.3
193
28
JAB30
NOMESCO Finland
Repair of inguinal hernia using prosthetic material
697.7
130.8
127
*
6123
FHL
Radical surgery
206.9
128.0
131
7
K46.0
ICD-10 Finland
Unspecified abdominal hernia with obstruction, without gangrene
1290.1
122.9
118
*
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.6
102.5
667
2865
K42.9
ICD-10 Finland
Umbilical hernia without obstruction or gangrene
74.4
102.3
116
17
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
+∞
99.2
94
*
K43.0
ICD-10 Finland
Incisional hernia with obstruction, without gangrene
950.1
91.9
89
*
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
89.0
553
2220
JAD10
NOMESCO Finland
Repair of incisional hernia
450.1
86.1
85
*
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.1
84.9
304
731
K44.9
ICD-10 Finland
Diaphragmatic hernia without obstruction or gangrene
27.7
79.6
110
43
5538X
ICD-9 Finland
Other hernia of abdominal cavity without mention of obstruction or gangrene, Hernia of other specified sites
+∞
71.5
68
*
UJF32
NOMESCO Finland
Coloscopy
3.1
68.7
508
2217
JAG00
NOMESCO Finland
Repair of other hernia
647.1
63.4
62
*
WX302
NOMESCO Finland
Thoracal epidural anesthesy
6.4
63.4
179
317
55199
ICD-8 Finland
Other hernia of abdominal cavity without mention of obstruction, Of unspecified site
+∞
61.9
59
*
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
8.9
61.4
136
167
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
9.5
61.4
131
151
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
10.8
58.1
115
115
N02AX02
ATC
tramadol; systemic, rectal
2.5
54.2
690
4001
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.7
54.0
482
2293
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
3.8
52.8
249
752
JAH00
NOMESCO Finland
Laparotomy
9.0
52.5
115
138
ZXD05
NOMESCO Finland
Urgent procedure
2.6
51.5
529
2708
55099
ICD-8 Finland
Inguinal hernia without mention of obstruction
+∞
50.3
48
*
Z93.3
ICD-10 Finland
Colostomy status
22.6
50.1
73
34
JAF10
NOMESCO Finland
Repair of umbilical hernia
41.1
47.3
59
15
JAG41
NOMESCO Finland
Repair of stomal hernia, laparoscopic
+∞
47.1
45
*
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
6.0
46.0
134
244
JAG96
NOMESCO Finland
Other reconstruction of abdominal wall
101.6
45.1
49
5
ZXE10
NOMESCO Finland
More than one and less than three hours
2.3
44.5
573
3238
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
4.1
44.4
186
501
TPH07
NOMESCO Finland
Cathetrisation of artery
3.5
44.4
229
738
JAF30
NOMESCO Finland
Repair of umbilical hernia using prosthetic material
+∞
44.0
42
*
JAH01
NOMESCO Finland
Laparoscopy
6.2
43.7
124
218
B01AB05
ATC
enoxaparin; parenteral
2.4
43.7
516
2785
ZXE20
NOMESCO Finland
More than three and less than five hours
3.0
42.4
278
1064
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
55.2
40.7
48
9
N02BE01
ATC
paracetamol; systemic, rectal
2.8
39.5
1194
9864
JAB11
NOMESCO Finland
Laparoscopic repair of inguinal hernia
140.8
38.9
41
*
JN3AD
NOMESCO Finland
Abdominal CT examination
3.8
38.9
178
516
K45.1
ICD-10 Finland
Other specified abdominal hernia with gangrene
+∞
38.7
37
*
JFB00
NOMESCO Finland
Partial resection of small intestine
12.7
38.7
70
58
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
6.3
38.5
107
183
TJF80
NOMESCO Finland
Ostomy education
14.1
38.3
66
49
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
10.4
37.6
75
76
D91
ICPC
Abdominal hernia other
25.9
36.0
50
20
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
82.4
36.0
40
5
GD1AA
NOMESCO Finland
Thorax X-ray examination
2.1
35.6
664
4291
55180
ICD-8 Finland
Other hernia of abdominal cavity without mention of obstruction, Of other specified site
+∞
35.6
34
*
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.3
34.8
191
635
K45
ICD-10 Finland
Other abdominal hernia
345.4
34.1
34
*
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
2.5
33.8
309
1424
6124
FHL
Radical cutting and plastic with foreign material
334.8
33.0
33
*
JGB30
NOMESCO Finland
Abdominoperineal excision of rectum
27.3
32.9
45
17
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.6
32.8
160
487
K56.7
ICD-10 Finland
Ileus, unspecified
9.2
31.6
67
76
J01MA02
ATC
ciprofloxacin; systemic
2.0
31.5
583
3693
JAG01
NOMESCO Finland
Laparoscopic repair of other hernia
+∞
31.4
30
*
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.7
31.2
236
972
K43
ICD-10 Finland
Ventral hernia
47.4
30.7
37
8
TPH04
NOMESCO Finland
Cathetrisation of vein
2.3
30.1
332
1674
JN4BD
NOMESCO Finland
Extensive body CT
2.8
29.9
218
878
P01AB01
ATC
metronidazole; oral, rectal
2.0
29.7
567
3612
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
11.2
27.9
53
49
SPAT1262
SPAT
Handing over of treatment supplies
2.3
27.9
320
1633
ZXD10
NOMESCO Finland
Scheduled procedure
1.9
27.8
544
3473
WF001
NOMESCO Finland
Preoperative radiotherapy
13.0
27.7
49
39
5509B
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,LATERALIS (SCROT]
+∞
27.2
26
*
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
10.2
27.1
54
55
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
7.6
26.9
64
88
K42.0
ICD-10 Finland
Umbilical hernia with obstruction, without gangrene
276.2
26.8
27
*
A03FA01
ATC
metoclopramide; systemic, rectal
2.2
26.2
332
1766
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.2
26.2
313
1623
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
6.9
26.0
66
100
Z93.2
ICD-10 Finland
Ileostomy status
31.6
26.0
34
11
JAG43
NOMESCO Finland
Repair of stomal hernia with mesh
+∞
25.1
24
*
ZXE00
NOMESCO Finland
One hour or less
1.9
25.1
549
3609
A02BC02
ATC
pantoprazole; systemic
1.9
25.0
882
6811
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
91.8
24.7
27
*
S18
ICPC
Laceration/cut
1.9
24.7
585
3943
A02BC05
ATC
esomeprazole; systemic
1.9
24.6
555
3680
WX402
NOMESCO Finland
General anaesthesia
2.3
23.5
237
1126
WZC30
NOMESCO Finland
Teaching
2.4
23.5
216
982
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
5.6
23.3
69
128
N02AA59
ATC
codeine, combinations excl. psycholeptics; systemic
1.8
23.0
627
4397
JAD96
NOMESCO Finland
Other repair of incisional hernia
+∞
23.0
22
*
JAP01
NOMESCO Finland
Laparoscopic freeing of adhesions in the peritoneal cavity
10.3
22.9
45
45
K40.2
ICD-10 Finland
Bilateral inguinal hernia, without obstruction or gangrene
66.1
22.9
26
*
JGB31
NOMESCO Finland
Laparoscopic and perineal excision of rectum
30.6
22.8
30
10
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
22.8
452
2844
J01DB01
ATC
cefalexin; oral
1.9
22.7
1074
9003
JFG50
NOMESCO Finland
Laparotomy with revision of enterostomy or colostomy
233.7
22.7
23
*
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
2.2
22.5
269
1387
QBJ30
NOMESCO Finland
Correction of abdominal apron
16.0
22.4
36
23
L01BC06
ATC
capecitabine; oral
4.2
22.0
86
215
JAD97
NOMESCO Finland
Other laparoscopic repair of incisional hernia
+∞
21.9
21
*
JAG51
NOMESCO Finland
Laparoscopic repair of internal hernia
+∞
21.9
21
*
5531A
ICD-9 Finland
Other hernia of abdominal cavity without mention of obstruction or gangrene, Umbilical hernia
+∞
21.9
21
*
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
2.2
21.8
241
1195
SPAT1125
SPAT
Stoma care and guidance
6.3
21.7
58
95
K43.2
ICD-10 Finland
Incisional hernia without obstruction or gangrene
223.4
21.7
22
*
A06AD11
ATC
lactulose; oral
2.2
21.6
236
1165
N39.0
ICD-10 Finland
Urinary tract infection, site not specified
2.3
21.2
225
1094
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
24.6
20.9
29
12
JAF11
NOMESCO Finland
Laparoscopic repair of umbilical hernia
+∞
20.9
20
*
5509A
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,MEDIALIS]
+∞
20.9
20
*
JAB10
NOMESCO Finland
Repair of inguinal hernia
78.0
20.7
23
*
R10.1
ICD-10 Finland
Pain localized to upper abdomen
2.2
20.6
240
1217
N03AX16
ATC
pregabalin; oral
1.9
20.5
338
1975
C03CA01
ATC
furosemide; systemic
1.8
20.4
443
2853
JDF11
NOMESCO Finland
Laparoscopic gastric bypass
9.8
20.4
41
43
N02AE01
ATC
buprenorphine; parenteral, sublingual, transdermal
2.3
20.3
212
1019
J01MA12
ATC
levofloxacin; systemic
2.0
20.1
286
1577
E66.8
ICD-10 Finland
Other obesity
3.7
19.9
90
257
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
3.1
19.9
114
390
6125
FHL
Residual surgery, can be reported as a side effect
+∞
19.8
19
*
5539X
ICD-9 Finland
Other hernia of abdominal cavity without mention of obstruction or gangrene, Hernia of unspecified site
+∞
19.8
19
*
5518X
ICD-9 Finland
Other hernia of abdominal cavity, with gangrene, Hernia of other specified sites, with gangrene
+∞
19.8
19
*
JFB60
NOMESCO Finland
Resection of sigmoid colon with end colostomy
15.6
19.8
32
21
R03AC02
ATC
salbutamol; inhalant
1.7
19.7
667
4912
6129
FHL
Other measure in this category
106.6
19.6
21
*
UKC02
NOMESCO Finland
Cystoscopy
2.1
19.5
252
1335
J01DA01
ATC
[U] cefalexin; systemic
1.7
19.1
825
6492
C20.92
ICD-10 Finland
Malignant tumor of the rectum carcinoma of the adenoma
12.0
18.8
34
29
WX704
NOMESCO Finland
Intubation
2.9
18.4
117
429
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.1
18.3
236
1248
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.2
18.1
96
311
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
5.9
17.8
50
88
WX110
NOMESCO Finland
Local anesthesy
1.7
17.8
835
6660
5532A
ICD-9 Finland
Other hernia of abdominal cavity without mention of obstruction or gangrene, Ventral hernia [incisional][HERNIA VENTRALIS SINE OBSTRUCTIONE ET GANGRAENA]
+∞
17.7
17
*
UJD02
NOMESCO Finland
Gastroscopy
3.5
17.7
85
255
JEA00
NOMESCO Finland
Appendectomy
3.1
17.7
102
350
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
3.8
17.6
75
204
K21.0
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
2.5
17.2
142
604
J45.9
ICD-10 Finland
Asthma, unspecified
2.0
17.1
246
1352
M01AE03
ATC
ketoprofen; systemic, rectal
1.7
17.0
513
3603
R10.0
ICD-10 Finland
Acute abdomen
4.4
16.8
61
143
UJG02
NOMESCO Finland
Proctoscopy
4.9
16.8
55
116
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.5
16.7
79
234
C20.99
ICD-10 Finland
Malignant tumor of the rectum other or unspecified histology
10.5
16.7
32
31
JAE10
NOMESCO Finland
Repair of epigastric hernia
+∞
16.7
16
*
H02AB06
ATC
prednisolone; systemic
1.6
16.7
613
4540
A02BC03
ATC
lansoprazole; oral
1.7
16.5
393
2569
N03AX12
ATC
gabapentin; oral
2.0
16.4
218
1160
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
3.5
16.4
78
233
SPAT1263
SPAT
Sampling
1.6
16.2
555
4024
130
Kela drug reimbursment
Malignant tumour
2.4
16.1
147
662
PH2AE
NOMESCO Finland
Ultrasound examination of lower leg veins
2.2
16.0
179
885
WX320
NOMESCO Finland
Spinalanesthesy
1.8
15.9
305
1861
SPAT1255
SPAT
Intravenous administration of medicine
2.7
15.8
115
454
L04AX01
ATC
azathioprine; systemic
3.4
15.8
77
234
B01AB10
ATC
tinzaparin; parenteral
2.6
15.8
116
464
SPAT1148
SPAT
Treatment of chronic ulcer or burn
2.0
15.7
211
1128
55121
ICD-8 Finland
Other hernia of abdominal cavity without mention of obstruction, Alia hernia ventralis (incisionalis, in cicactrice)
+∞
15.6
15
*
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
2.2
15.6
168
817
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.2
15.6
169
823
D01
ICPC
Abdominal pain/cramps general
2.4
15.4
135
595
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.0
15.3
93
330
N17.9
ICD-10 Finland
Acute renal failure, unspecified
3.4
15.3
75
229
K57.2
ICD-10 Finland
Diverticular disease of large intestine with perforation and abscess
5.0
15.3
49
101
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
2.1
15.2
192
1001
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.4
15.1
74
226
T81.0
ICD-10 Finland
Haemorrhage and haematoma complicating a procedure, not elsewhere classified
2.9
15.1
96
352
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.4
15.0
134
595
203
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
1.9
14.9
262
1545
K50.1
ICD-10 Finland
Crohn disease of large intestine
8.4
14.8
32
39
K50.9
ICD-10 Finland
Crohn disease, unspecified
6.9
14.7
36
53
A07EC02
ATC
mesalazine; oral, rectal
3.0
14.7
89
315
Z3226
NOMESCO Finland
Physiotherapist
1.9
14.6
259
1530
X59
ICD-10 Finland
Exposure to unspecified factor
1.9
14.6
237
1357
SPAT1153
SPAT
Removal of sutures
1.7
14.6
432
2990
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.9
14.3
234
1345
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.9
14.3
225
1274
Z01.8
ICD-10 Finland
Other specified special examinations
1.8
14.0
283
1748
A03FA02
ATC
cisapride; oral, rectal
2.4
13.9
127
568
D37.5
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Rectum
8.3
13.8
30
37
N02AA05
ATC
oxycodone; systemic
1.9
13.8
221
1261
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
3.9
13.8
56
147
K59.09
ICD-10 Finland
Constipation, unspecified
2.7
13.7
99
391
5509D
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,RECIDIVANS]
+∞
13.6
13
*
K43.1
ICD-10 Finland
Incisional hernia with gangrene
+∞
13.6
13
*
A06AC01
ATC
ispaghula (psylla seeds); oral
1.7
13.4
323
2100
SPAT1254
SPAT
Administration of medicine
1.9
13.4
216
1234
K50.8
ICD-10 Finland
Other Crohn disease
6.3
13.4
35
57
C20
ICD-10 Finland
Malignant neoplasm of rectum
7.1
13.4
32
46
R11
ICD-10 Finland
Nausea and vomiting
2.4
13.4
116
508
Z93
ICD-10 Finland
Artificial opening status
21.4
13.3
19
9
R4110
NOMESCO Finland
Physiotherapy
1.7
13.3
344
2282
M54.5
ICD-10 Finland
Low back pain
1.6
13.2
393
2704
K46
ICD-10 Finland
Unspecified abdominal hernia
40.5
13.2
16
*
ZX120
NOMESCO Finland
Intravenous
2.2
13.1
141
682
J01DA09
ATC
[U] cefadroxil; inhalant, oral
1.7
13.1
348
2322
RD210
NOMESCO Finland
NA
5.3
13.1
39
75
KBJ10
NOMESCO Finland
Cutaneous ureteroenterostomy
9.4
13.0
26
28
JFF23
NOMESCO Finland
Transversostomy
7.0
12.9
31
45
R06.0
ICD-10 Finland
Dyspnoea
1.7
12.8
333
2205
M79.6
ICD-10 Finland
Pain in limb
1.6
12.8
441
3151
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
7.3
12.8
30
42
JA1AE
NOMESCO Finland
Ultrasound examination of groin and abdominal wall
6.1
12.7
34
57
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
3.7
12.7
56
158
JKA20
NOMESCO Finland
Cholecystectomy
3.7
12.7
56
158
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
2.3
12.7
117
529
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.3
12.6
116
524
K46.1
ICD-10 Finland
Unspecified abdominal hernia with gangrene
+∞
12.5
12
*
D99
ICPC
Disease digestive system other
7.4
12.5
29
40
A02BC01
ATC
omeprazole; systemic
1.6
12.5
364
2488
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
24.5
12.5
17
7
K44.0
ICD-10 Finland
Diaphragmatic hernia with obstruction, without gangrene
131.1
12.5
13
*
J01FA06
ATC
roxithromycin; oral
1.6
12.4
510
3796
R07.4
ICD-10 Finland
Chest pain, unspecified
1.6
12.4
351
2378
Z3231
NOMESCO Finland
Registered nurse
1.6
12.4
351
2379
TKC20
NOMESCO Finland
Catheterisation of bladder
2.4
12.4
109
480
D75
ICPC
Malignant neoplasm colon/rectum
8.1
12.3
27
34
E66.9
ICD-10 Finland
Obesity, unspecified
3.5
12.3
56
163
T81.9
ICD-10 Finland
Unspecified complication of procedure
5.2
12.2
37
73
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
5.9
12.1
33
57
K51.5
ICD-10 Finland
Left sided colitis
4.0
12.1
48
124
R51.80
ICD-10 Finland
Headache
2.0
12.1
171
927
N02AJ06
ATC
codeine and paracetamol; systemic
1.6
12.1
434
3125
M01AB05
ATC
diclofenac; systemic, rectal
1.5
12.0
816
6785
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
7.6
11.9
27
36
C07AB07
ATC
bisoprolol; oral
1.5
11.9
625
4904
R50.9
ICD-10 Finland
Fever, unspecified
1.9
11.9
181
1010
SPAT1301
SPAT
No procedures
1.6
11.8
414
2961
JG1BG
NOMESCO Finland
MRI of rectum
8.5
11.8
25
30
D06
ICPC
Abdominal pain localized other
2.4
11.8
101
441
JN4AD
NOMESCO Finland
Body CT examination
2.2
11.7
120
567
J01CR02
ATC
amoxicillin and beta-lactamase inhibitor; systemic
1.5
11.7
605
4727
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
2.5
11.7
92
384
WX892
NOMESCO Finland
Monitored bed care
2.3
11.7
110
500
JFH10
NOMESCO Finland
Total colectomy and ileostomy
30.3
11.6
15
5
SPAT1230
SPAT
Aid fitting and borrowing and monitoring of use
1.8
11.6
234
1435
WX002
NOMESCO Finland
Sedation and analgesia
1.7
11.6
251
1571
Z2446
NOMESCO Finland
Social worker
2.4
11.6
99
431
JAG97
NOMESCO Finland
Other laparoscopic reconstruction of abdominal wall
121.0
11.4
12
*
J01EE02
ATC
sulfadiazine and trimethoprim; systemic
1.6
11.4
314
2106
K51.1
ICD-10 Finland
Ulcerative (chronic) ileocolitis
7.9
11.4
25
32
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
7.0
11.3
27
39
WZB00
NOMESCO Finland
Telephone receipt or other advice
1.6
11.3
331
2253
QX2XE
NOMESCO Finland
Ultrsound examination of soft tissue not elsewhere classified
3.5
11.3
51
148
A12AX
ATC
Calcium, combinations with vitamin D and/or other drugs
1.5
11.2
444
3259
K56.0
ICD-10 Finland
Paralytic ileus
6.9
11.2
27
40
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
4.1
11.2
42
104
XF400
NOMESCO Finland
ECG with 12 standard connections
1.8
11.1
223
1367
J01EA01
ATC
trimethoprim; systemic
1.6
11.0
331
2270
FM1EE
NOMESCO Finland
Extensive structural and functional ultrasound examination of heart
1.7
10.9
282
1856
L28
ICPC
Limited function/disability (L)
1.8
10.8
218
1335
H02AB04
ATC
methylprednisolone; systemic
1.8
10.8
186
1081
E66.01
ICD-10 Finland
Obesity due to excess calories
2.3
10.8
99
445
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.9
10.8
152
825
J01AA02
ATC
doxycycline; systemic
1.5
10.7
995
8740
R03AC12
ATC
salmeterol; inhalant
2.7
10.6
71
270
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
9.3
10.5
21
23
G47.3
ICD-10 Finland
Sleep apnoea
1.7
10.4
254
1644
JAE11
NOMESCO Finland
Laparoscopic repair of epigastric hernia
+∞
10.4
10
*
K43.5
ICD-10 Finland
Parastomal hernia without obstruction or gangrene
+∞
10.4
10
*
M25.5
ICD-10 Finland
Pain in joint
1.6
10.4
327
2266
A07EA02
ATC
hydrocortisone; rectal
3.7
10.3
44
122
R03AC03
ATC
terbutaline; inhalant
1.8
10.3
173
998
A02BA02
ATC
ranitidine; systemic
1.7
10.3
260
1700
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
13.2
10.2
17
13
JGB00
NOMESCO Finland
Partial proctectomy and colorectal or coloanal anastomosis
10.1
10.0
19
19
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.6
10.0
312
2152
WX882
NOMESCO Finland
High dependency care
3.5
10.0
45
131
J01CA04
ATC
amoxicillin; systemic
1.5
10.0
978
8604
JFF26
NOMESCO Finland
Sigmoidostomy
40.4
10.0
12
*
SPAT1149
SPAT
Suture or treatment of traumatic wound
1.8
10.0
177
1038
SPAT1249
SPAT
Treatment-related counselling outside office
1.5
10.0
485
3705
SPAT1253
SPAT
Initiation, adjustment, discontinuation or repetition of medication
1.5
9.9
391
2847
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.0
9.7
124
649
J15.9
ICD-10 Finland
Bacterial pneumonia, unspecified
2.0
9.7
121
624
M01AH01
ATC
celecoxib; oral (coxibs)
1.7
9.6
233
1504
R07.3
ICD-10 Finland
Other chest pain
2.0
9.6
121
628
7890A
ICD-9 Finland
Other symptoms involving abdomen and pelvis, Abdominal pain
2.5
9.6
77
324
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.3
9.5
84
373
L02.2
ICD-10 Finland
Cutaneous abscess, furuncle and carbuncle of trunk
2.8
9.5
59
213
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
2.2
9.5
100
480
EB1HA
NOMESCO Finland
Panorama tomography of teeth and jaws or similar X-ray examination
1.5
9.5
458
3485
JKA21
NOMESCO Finland
Laparoscopic cholecystectomy
1.9
9.4
139
765
JG1CG
NOMESCO Finland
Extensive MRI of rectum
7.6
9.4
21
28
A41.9
ICD-10 Finland
Sepsis, unspecified
2.8
9.4
59
216
55110
ICD-8 Finland
Other hernia of abdominal cavity without mention of obstruction, Umbilical
+∞
9.4
9
*
A07EA06
ATC
budesonide; oral, local oral
3.1
9.4
50
166
F32.2
ICD-10 Finland
Severe depressive episode without psychotic symptoms
2.5
9.3
73
305
K66.0
ICD-10 Finland
Peritoneal adhesions
10.7
9.3
17
16
K40
ICD-10 Finland
Inguinal hernia
9.6
9.3
18
19
NA3BG
NOMESCO Finland
Lumbar spine MRI examination with high intensity magnet
2.0
9.3
122
642
K50.0
ICD-10 Finland
Crohn disease of small intestine
5.3
9.2
27
52
J45.0
ICD-10 Finland
Predominantly allergic asthma
2.1
9.2
101
495
Z2221
NOMESCO Finland
Medical doctor
1.5
9.2
330
2346
G04CA02
ATC
tamsulosin; oral
1.6
9.1
281
1928
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.4
9.1
42
125
K21.9
ICD-10 Finland
Gastro-oesophageal reflux disease without oesophagitis
2.0
9.1
111
569
N05CF01
ATC
zopiclone; oral
1.5
9.1
416
3122
NA3AA
NOMESCO Finland
Lumbar spine X-ray examination without contrast
2.0
9.1
121
642
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.8
9.1
57
209
K65.0
ICD-10 Finland
Acute peritonitis
5.4
9.1
26
49
JFF10
NOMESCO Finland
Loop enterostomy
8.4
9.1
19
23
M17.1
ICD-10 Finland
Other primary gonarthrosis
1.6
9.1
272
1855
WX290
NOMESCO Finland
Other blockade of nerve
1.5
9.1
448
3418
QBE15
NOMESCO Finland
Excision of other superficial lesion of skin of trunk
9.1
9.0
18
20
JAH33
NOMESCO Finland
Opening of laparostomy
36.9
9.0
11
*
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
6.6
9.0
22
34
JFF30
NOMESCO Finland
Other colostomy
24.2
8.9
12
5
K40.3
ICD-10 Finland
Unilateral or unspecified inguinal hernia, with obstruction, without gangrene
24.2
8.9
12
5
R42
ICD-10 Finland
Dizziness and giddiness
1.6
8.9
273
1873
B01AB04
ATC
dalteparin; parenteral
2.4
8.9
73
313
I10
ICD-10 Finland
Essential (primary) hypertension
1.4
8.8
753
6363
QBA10
NOMESCO Finland
Incision of skin of trunk
5.2
8.8
26
51
R33
ICD-10 Finland
Retention of urine
2.0
8.8
111
579
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.6
8.8
60
233
M54.9
ICD-10 Finland
Dorsalgia, unspecified
1.9
8.7
133
741
R03AK06
ATC
salmeterol and fluticasone; inhalant
1.7
8.7
173
1055
EB1AA
NOMESCO Finland
Tooth X-ray examination
1.4
8.7
614
5006
J01FF01
ATC
clindamycin; systemic
1.5
8.6
341
2479
N02AC04
ATC
dextropropoxyphene; oral
2.5
8.6
63
256
M01AC06
ATC
meloxicam; systemic, rectal
1.4
8.5
446
3432
LC2BE
NOMESCO Finland
Transvaginal ultrasound examination of uterus, parametria and lower abdomen
1.6
8.5
270
1861
Z43.2
ICD-10 Finland
Attention to ileostomy
27.7
8.5
11
*
M03BX02
ATC
tizanidine; oral
1.4
8.4
707
5933
X57
ICD-10 Finland
Unspecified privation
3.5
8.4
38
112
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.4
8.4
67
282
SPAT1306
SPAT
Counselling and guidance related to nutrition and weight management
1.7
8.4
178
1105
J20.9
ICD-10 Finland
Acute bronchitis, unspecified
1.6
8.4
213
1388
JAG46
NOMESCO Finland
Repair of recurrent stomal hernia, laparoscopic
+∞
8.3
8
*
ZXA05
NOMESCO Finland
Left side
1.5
8.3
317
2281
JFB46
NOMESCO Finland
Resection of sigmoid colon
4.4
8.3
28
64
K56.2
ICD-10 Finland
Volvulus
7.6
8.2
18
24
R03BA02
ATC
budesonide; inhalant
1.6
8.2
205
1332
K02.1
ICD-10 Finland
Caries of dentine
1.4
8.1
613
5036
JFH20
NOMESCO Finland
Proctocolectomy and ileostomy
33.5
8.1
10
*
TKC22
NOMESCO Finland
Catheterisation instruction
3.2
8.1
40
127
D01AC02
ATC
miconazole; topical
2.0
8.1
103
538
M02AA07
ATC
piroxicam; topical
1.4
8.0
460
3591
A46
ICD-10 Finland
Erysipelas
1.7
8.0
186
1184
SPAT1325
SPAT
Vaccination
1.4
8.0
441
3413
F32.9
ICD-10 Finland
Depressive episode, unspecified
1.9
8.0
124
695
S06.0
ICD-10 Finland
Concussion
1.9
8.0
122
680
M01AH05
ATC
etoricoxib; oral
1.4
7.9
672
5622
5742A
ICD-9 Finland
Cholelithiasis, Calculus of gallbladder without mention of cholecystitis[CHOLECYSTOLITHIASIS SINE CHOLECYSTITIDE,SINE OBSTR]
3.0
7.9
43
146
B03BA03
ATC
hydroxocobalamin; parenteral
2.2
7.9
82
393
J01CA08
ATC
pivmecillinam; oral
1.4
7.8
458
3590
A41.0
ICD-10 Finland
Sepsis due to Staphylococcus aureus
3.6
7.8
33
93
T36
ICD-10 Finland
Poisoning by systemic antibiotics
2.8
7.8
49
180
H02AB07
ATC
prednisone; oral
1.7
7.8
177
1122
Z93.8
ICD-10 Finland
Other artificial opening status
45.2
7.7
9
*
L30.9
ICD-10 Finland
Dermatitis, unspecified
1.6
7.7
208
1378
WX105
NOMESCO Finland
Surface analgesia on skin or mucosa
1.9
7.6
104
560
TPX10
NOMESCO Finland
Implantation of vascular injection port
2.9
7.6
44
155
JFA70
NOMESCO Finland
Suture of small intestine
11.9
7.6
13
11
JFG36
NOMESCO Finland
Closure of terminal colostomy with anastomosis to rectum
25.1
7.6
10
*
JAB00
NOMESCO Finland
Division and ligature of inguinal hernia sac
25.1
7.6
10
*
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
7.5
71
328
M51.1
ICD-10 Finland
Lumbar and other intervertebral disc disorders with radiculopathy
1.7
7.5
165
1031
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
7.5
77
368
XF600
NOMESCO Finland
Bloodpressure measurement
2.1
7.5
84
418
R03DC03
ATC
montelukast; oral
1.7
7.4
175
1116
K41.9
ICD-10 Finland
Unilateral or unspecified femoral hernia, without obstruction or gangrene
80.5
7.4
8
*
JGB36
NOMESCO Finland
Wide excision of rectum
80.5
7.4
8
*
JAG50
NOMESCO Finland
Repair of internal hernia
80.5
7.4
8
*
D64.9
ICD-10 Finland
Anaemia, unspecified
1.8
7.4
130
762
N06AA09
ATC
amitriptyline; systemic
1.8
7.4
128
746
J02AC01
ATC
fluconazole; systemic
1.4
7.4
434
3390
AA1AD
NOMESCO Finland
CT of head and brain
1.5
7.4
299
2175
R52.0
ICD-10 Finland
Acute pain
2.9
7.3
43
153
K30
ICD-10 Finland
Functional dyspepsia
1.8
7.3
120
686
U07
ICPC
Urine symptom/complaint other
2.1
7.3
76
366
5509X
ICD-9 Finland
Inguinal hernia, without mention of obstruction or gangrene[HERNIA INGUINALIS SINE GANGR/OBSTR,ALIA SEU NUD]
+∞
7.3
7
*
5530A
ICD-9 Finland
Other hernia of abdominal cavity without mention of obstruction or gangrene, Femoral hernia
+∞
7.3
7
*
5512A
ICD-9 Finland
Other hernia of abdominal cavity, with gangrene, Ventral hernia with gangrene[HERNIA VENTRALIS CUM GANGRAENA]
+∞
7.3
7
*
JAG47
NOMESCO Finland
Repair of recurrent stomal hernia with mesh
+∞
7.3
7
*
JBB01
NOMESCO Finland
Laparoscopic repair of paraoesophageal hernia
+∞
7.3
7
*
G56.0
ICD-10 Finland
Carpal tunnel syndrome
1.7
7.3
155
960
SPAT1256
SPAT
Intramuscular and subcutaneous injection
1.4
7.3
508
4094
TK800
NOMESCO Finland
Hemodialysis
3.4
7.2
33
99
KCC30
NOMESCO Finland
Cystectomy with excision of female internal genital organs
15.8
7.2
11
7
N06AX21
ATC
duloxetine; oral
1.8
7.2
119
680
J45.1
ICD-10 Finland
Nonallergic asthma
2.0
7.2
89
461
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
2.2
7.2
68
314
SAA01
NOMESCO Finland
Simple examination of mouth
1.4
7.2
779
6744
K59.1
ICD-10 Finland
Functional diarrhoea
2.3
7.2
63
282
SPAT1137
SPAT
Taking care of patient’s/customer’s hygiene
2.0
7.2
84
426
Z71.8
ICD-10 Finland
Other specified counselling
1.5
7.1
255
1802
R05
ICD-10 Finland
Cough
1.5
7.1
226
1553
I25.1
ICD-10 Finland
Atherosclerotic heart disease
1.5
7.1
280
2021
G40.9
ICD-10 Finland
Epilepsy, unspecified
2.7
7.1
47
181
XX3DW
NOMESCO Finland
Time consuming IT work
1.8
7.1
132
785
WX610
NOMESCO Finland
Patient controlled analgesia
8.0
7.1
15
19
M03BA52
ATC
carisoprodol, combinations excl. psycholeptics; oral
2.4
7.1
56
236
F33.9
ICD-10 Finland
Recurrent depressive disorder, unspecified
2.8
7.1
42
151
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
4.6
7.1
23
51
Y60
ICD-10 Finland
Unintentional cut, puncture, perforation or haemorrhage during surgical and medical care
5.3
7.1
20
38
JH1CG
NOMESCO Finland
Extensive MRI of perianal area
10.1
7.0
13
13
SPAT1250
SPAT
Comprehensive monitoring of chronic illness
1.4
7.0
356
2703
WX872
NOMESCO Finland
Intensive care
2.3
7.0
64
291
N30.0
ICD-10 Finland
Acute cystitis
1.6
7.0
165
1054
C64.88
ICD-10 Finland
Other malignant neoplasm of kidney, except renal pelvis
3.2
7.0
35
113
N39.4
ICD-10 Finland
Other specified urinary incontinence
1.9
7.0
104
575
Z03.9
ICD-10 Finland
Observation for suspected disease or condition, unspecified
1.6
7.0
203
1369
X69
ICD-10 Finland
Intentional self-poisoning by and exposure to other and unspecified chemicals and noxious substances
3.1
6.9
35
114
QBG20
NOMESCO Finland
Operation for chronic ulcer or fistula of skin of trunk
13.8
6.9
11
8
A28
ICPC
Limited function/disability NOS
1.6
6.9
186
1230
NA1AD
NOMESCO Finland
Cervical spine CT examination
2.5
6.9
52
216
N06AB03
ATC
fluoxetine; oral
1.7
6.9
148
923
K59.0
ICD-10 Finland
Constipation
2.1
6.8
77
383
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.2
6.8
65
302
R06AE07
ATC
cetirizine; oral
1.4
6.8
484
3899
WYA30
NOMESCO Finland
Preparations for expected poor cooperation
1.9
6.7
97
532
A01AB09
ATC
miconazole; local oral
1.8
6.7
115
666
JFF27
NOMESCO Finland
Laparoscopic sigmoidostomy
16.8
6.7
10
6
MCA10
NOMESCO Finland
Lower uterine segment caesarean section
2.2
6.7
67
317
UJF30
NOMESCO Finland
Ileoscopy through colon
1.8
6.7
113
651
C10AC01
ATC
colestyramine; oral
2.8
6.7
40
145
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
7.2
6.7
15
21
R03BA05
ATC
fluticasone; inhalant
1.6
6.7
203
1381
N18.9
ICD-10 Finland
Chronic kidney disease, unspecified
2.0
6.7
80
407
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
3.2
6.7
33
106
6435
FHL
Abdominoperineal resection and colostomy
22.6
6.7
9
*
A02BA04
ATC
nizatidine; systemic
1.9
6.6
98
544
JN2CG
NOMESCO Finland
Extensive MRI examination of lower part of abdoment with high intensity magnet
3.6
6.6
28
80
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.9
6.6
25
65
N03AE01
ATC
clonazepam; systemic
2.1
6.6
75
375
R05FA02
ATC
opium derivatives and expectorants; systemic
1.4
6.6
471
3795
JFF13
NOMESCO Finland
Terminal enterostomy
12.3
6.6
11
9
JF1AD
NOMESCO Finland
Small bowel CT
8.7
6.6
13
15
F32.10
ICD-10 Finland
Moderate depressive episode without somatic syndrome
2.0
6.5
79
404
J69.0
ICD-10 Finland
Pneumonitis due to food and vomit
3.4
6.5
29
86
Z43.3
ICD-10 Finland
Attention to colostomy
10.1
6.5
12
12
Z00.4
ICD-10 Finland
General psychiatric examination, not elsewhere classified
2.0
6.5
85
448
WYA05
NOMESCO Finland
Emergency visit or other similar visit involving procedures
1.4
6.5
517
4232
WX725
NOMESCO Finland
Noninvasive ventilation
2.2
6.5
63
295
J01DA06
ATC
[U] cefuroxime; systemic
1.6
6.5
167
1091
K57.9
ICD-10 Finland
Diverticular disease of intestine, part unspecified, without perforation or abscess
3.1
6.4
33
109
SPAT1223
SPAT
Implementation of physical therapy rehabilitation plan
1.4
6.4
353
2714
M54
ICD-10 Finland
Dorsalgia
1.7
6.4
118
703
J20
ICD-10 Finland
Acute bronchitis
1.8
6.4
109
632
JAH30
NOMESCO Finland
Laparostomy
70.1
6.4
7
*
S97
ICPC
Chronic ulcer skin
2.0
6.4
74
375
Z09.0
ICD-10 Finland
Follow-up examination after surgery for other conditions
1.9
6.4
90
491
N06AB04
ATC
citalopram; systemic
1.5
6.4
247
1774
K29.7
ICD-10 Finland
Gastritis, unspecified
2.6
6.4
45
180
C01DA08
ATC
isosorbide dinitrate; oral, oral aerosol, sublingual, transdermal
1.4
6.3
291
2161
JF1BD
NOMESCO Finland
Very extensive small bowel CT
6.6
6.3
15
23
D29
ICPC
Digestive symptom/complaint other
3.4
6.3
28
83
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
5.2
6.3
18
35
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.7
6.3
39
146
SFA10
NOMESCO Finland
Fillning on one surface of tooth
1.3
6.3
565
4709
M79.1
ICD-10 Finland
Myalgia
1.7
6.3
142
896
T82
ICPC
Obesity
2.6
6.3
44
174
A04
ICPC
Weakness/tiredness general
1.6
6.3
150
964
JFG26
NOMESCO Finland
Closure of terminal enterostomy with anastomosis to colon
+∞
6.3
6
*
K43.3
ICD-10 Finland
Parastomal hernia with obstruction, without gangrene
+∞
6.3
6
*
A01
ICPC
Pain general/multiple sites
1.9
6.2
91
502
X58
ICD-10 Finland
Exposure to other specified factors
1.6
6.2
145
923
NGB20
NOMESCO Finland
Primary total prosthetic replacement of knee joint without patellar part
1.7
6.2
129
794
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
26.8
6.2
8
*
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
26.8
6.2
8
*
YL1BD
NOMESCO Finland
Extensive CT examination of pelvis for dose design of radiotherapy
3.0
6.2
33
112
I48
ICD-10 Finland
Atrial fibrillation and flutter
1.4
6.2
287
2137
ZXA10
NOMESCO Finland
Bilateral
1.5
6.2
221
1557
A04.7
ICD-10 Finland
Enterocolitis due to Clostridium difficile
2.8
6.2
37
135
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
3.7
6.2
25
69
SPAT1222
SPAT
Counselling/guidance promoting independent living
1.5
6.2
186
1263
M17.0
ICD-10 Finland
Primary gonarthrosis, bilateral
1.6
6.1
165
1089
56310
ICD-8 Finland
Chronic enteritis and ulcerative colitis, Ulcerative colitis
7.7
6.1
13
17
205
Kela drug reimbursment
Chronic hypertension
1.4
6.1
363
2824
A03CA02
ATC
clidinium and psycholeptics; oral
2.0
6.1
78
410
R4190
NOMESCO Finland
Nutritional therapy
2.7
6.1
38
143
SPAT1260
SPAT
Consultation of another employee
1.5
6.1
213
1496
K51.8
ICD-10 Finland
Other ulcerative colitis
3.9
6.1
23
60
A04AA01
ATC
ondansetron; systemic, rectal
1.9
6.1
84
455
5562A
ICD-9 Finland
Idiopathic proctocolitis, Ulcerative (chronic) proctitis
12.6
6.1
10
8
SPAT1312
SPAT
General health counselling
1.4
6.1
360
2802
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
6.1
300
2262
G44.2
ICD-10 Finland
Tension-type headache
1.6
6.0
137
868
U76
ICPC
Malignant neoplasm of bladder
10.1
6.0
11
11
M54.4
ICD-10 Finland
Lumbago with sciatica
1.6
6.0
173
1163
D18
ICPC
Change in faeces/bowel movements
2.9
6.0
33
115
A08.4
ICD-10 Finland
Viral intestinal infection, unspecified
2.8
6.0
36
132

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
663
3749
2.38
56.93
3.3
2.4
u/l
57.1
57.5
0.05
607
3437
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
955
6355
2.39
55.73
8.0
6.1
umol/l
10.4
11.6
3.93
912
6016
(3023368) Bacteria identified in Blood by Culture
611
3498
2.26
49.14
5.3
4.2
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
843
5574
2.18
46.37
5.7
4.1
—
—
—
0
0
(3013826) Glucose [Moles/volume] in Serum or Plasma
1008
7196
2.23
45.05
6.6
4.7
mmol/l
6.9
6.8
0.24
968
6742
(3044640) Blood type and Crossmatch panel - Blood
625
3806
2.10
41.13
3.3
2.5
—
—
—
0
0
(3012095) Magnesium [Moles/volume] in Serum or Plasma
383
2005
2.22
36.43
4.3
3.2
mmol/l
0.8
0.8
1.35
357
1868
(3024561) Albumin [Mass/volume] in Serum or Plasma
794
5436
1.98
36.25
8.0
4.6
g/l
34.2
35.2
5.20
760
5025
(3032080) INR in Blood by Coagulation assay
760
5165
1.96
35.03
10.8
9.9
inr
1.2
1.3
0.74
236
1491
(3031040) Bacteria [#/volume] in Urine by Automated count
1055
8031
2.07
34.97
6.6
4.6
e6/l
482.6
2124.1
—
9
135
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
282
1318
2.40
34.87
6.8
4.0
ug/l
11.6
15.2
0.28
242
1090
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
491
2890
2.04
34.01
3.1
2.4
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
217
908
2.63
33.90
1.9
1.6
—
—
—
0
0
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
294
1426
2.32
33.27
8.7
7.7
kpa
5.2
5.1
0.42
284
1354
(3027801) Oxygen [Partial pressure] in Arterial blood
294
1427
2.32
33.21
8.6
7.7
kpa
12.4
12.1
0.44
284
1358
(3003458) Phosphate [Moles/volume] in Serum or Plasma
331
1690
2.23
33.12
7.1
5.1
mmol/l
1.1
1.0
0.74
317
1560
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1173
9402
2.15
32.25
10.5
7.3
u/l
78.9
79.7
0.29
1105
8793
(3003396) Base excess in Arterial blood by calculation
292
1430
2.30
32.22
8.7
7.7
mmol/l
1.3
1.3
0.03
242
1115
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
866
6258
1.91
32.08
9.5
6.6
mmol/l
1.2
1.2
6.42
745
5240
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
801
5653
1.90
31.81
8.4
5.9
mmol/l
1.2
1.2
5.34
740
5074
(3016502) Oxygen saturation in Arterial blood
264
1274
2.30
29.99
8.8
8.1
%
96.3
95.3
2.22
256
1223
(3007853) Bacteria identified in Skin by Aerobe culture
280
1396
2.24
29.38
1.9
1.7
—
—
—
0
0
(3002173) Hemoglobin [Mass/volume] in Arterial blood
248
1183
2.31
28.88
9.1
8.4
g/l
120.4
120.8
0.11
238
1131
(3014111) Lactate [Moles/volume] in Serum or Plasma
229
1064
2.36
28.30
7.6
7.2
mmol/l
1.3
1.4
0.38
224
1024
(3013650) Neutrophils [#/volume] in Blood by Automated count
916
6898
1.85
28.13
10.9
8.9
e9/l
4.4
4.2
2.01
821
6007
(3026008) Bacteria identified in Urine by Culture
594
3942
1.84
27.39
4.3
3.3
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
499
3135
1.89
27.39
2.9
2.1
mg/l
3.2
3.0
0.74
429
2640
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
227
1068
2.33
27.20
3.8
2.2
u/l
39.5
36.4
0.12
205
906
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
257
1302
2.18
25.66
2.8
2.5
umol/l
7.6
8.4
0.19
221
1129
(3001122) Ferritin [Mass/volume] in Serum or Plasma
698
4945
1.77
25.26
3.8
2.7
ug/l
114.7
138.6
2.33
649
4513
(3000991) Gas panel - Venous blood
214
1025
2.27
24.45
9.4
8.6
—
—
—
0
0
(3002032) Base excess in Venous blood by calculation
233
1172
2.17
23.56
4.8
3.4
mmol/l
1.9
2.0
0.19
191
921
(3020779) Urea [Moles/volume] in Serum or Plasma
224
1119
2.18
23.01
7.9
6.7
mmol/l
10.1
10.5
0.37
213
1061
(3037467) Urinalysis macro (dipstick) panel - Urine
1036
8339
1.79
23.01
6.1
4.4
—
—
—
0
0
(3019060) Gas panel - Arterial blood
185
857
2.32
22.80
6.2
4.8
—
—
—
0
0
(3006315) Basophils [#/volume] in Blood
789
5898
1.72
22.71
6.7
5.5
e9/l
0.0
0.0
0.04
686
5068
(3001604) Monocytes [#/volume] in Blood
782
5879
1.69
21.63
6.7
5.5
e9/l
0.6
0.6
0.35
680
5038
(3013115) Eosinophils [#/volume] in Blood
806
6114
1.69
21.50
6.8
5.8
e9/l
0.2
0.2
1.45
711
5324
(3042936) Bacteria identified in Isolate by Culture
302
1723
1.94
21.49
2.5
2.0
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
306
1763
1.93
21.11
2.9
2.4
g/l
2.4
2.3
1.94
284
1632
(3002582) Erythrocytes [#/volume] in Urine
546
3760
1.71
20.70
4.6
3.2
e6/l
132.0
85.5
0.25
452
2930
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
664
4818
1.68
20.69
4.4
3.7
ng/l
47.3
60.6
0.34
496
3494
(3019198) Lymphocytes [#/volume] in Blood
794
6038
1.67
20.65
6.8
5.6
e9/l
2.1
1.9
0.41
698
5285
(3013707) Erythrocyte sedimentation rate by Westergren method
1077
8905
1.75
20.23
4.7
4.0
mm/h
15.1
13.3
3.03
1002
8184
(3000208) Alpha tocopherol [Moles/volume] in Serum or Plasma
28
37
7.69
19.99
3.1
1.4
umol/l
30.2
32.4
0.38
28
37
(3006504) Eosinophils/100 leukocytes in Blood
739
5548
1.66
19.94
6.9
5.7
%
2.9
2.8
0.48
691
5139
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
401
2556
1.78
19.86
1.9
1.7
mg/l
1.1
1.3
0.76
313
1986
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
102
379
2.82
19.85
1.4
1.2
—
—
—
0
0
(3000850) Epithelial cells [#/volume] in Urine
413
2659
1.76
19.74
3.5
2.5
e6/l
5.3
5.8
0.32
373
2337
(3019069) Monocytes/100 leukocytes in Blood
741
5582
1.65
19.61
7.2
6.0
%
8.4
8.7
1.63
694
5195
(3035350) Ketones [Presence] in Urine by Test strip
764
5813
1.64
19.33
4.8
3.8
estimate
0.0
0.0
0.00
169
1136
(42870588) Differential panel, method unspecified - Blood
572
4055
1.67
19.05
6.5
5.5
—
—
—
0
0
(3022145) Colonoscopy Study observation
235
1280
1.99
18.95
1.4
1.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
136
596
2.41
18.92
1.5
1.2
—
—
—
0
0
(3022096) Basophils/100 leukocytes in Blood
717
5396
1.63
18.75
7.0
5.7
%
0.6
0.7
2.30
668
5005
(3008152) Bicarbonate [Moles/volume] in Arterial blood
167
804
2.21
18.66
9.2
6.9
mmol/l
25.0
24.7
0.42
155
744
(3002030) Lymphocytes/100 leukocytes in Blood
749
5706
1.63
18.58
7.0
5.8
%
26.7
27.1
0.42
696
5292
(3018010) Neutrophils/100 leukocytes in Blood
740
5623
1.63
18.53
6.7
5.6
%
58.2
57.8
0.31
688
5232
(3022948) Iron [Moles/volume] in Serum or Plasma
317
1924
1.82
18.32
3.0
2.4
umol/l
11.6
12.9
2.81
296
1770
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
337
2086
1.79
18.23
2.0
1.8
—
—
—
0
0
(3030467) Casts [#/volume] in Urine by Automated count
495
3426
1.67
17.82
4.6
3.1
e6/l
0.3
0.5
1.24
398
2630
(3018418) pH of Serum or Plasma
529
3729
1.65
17.70
5.6
3.9
ph
7.4
7.4
1.12
122
733
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
538
3809
1.64
17.69
2.3
2.2
u/l
233.5
204.9
0.34
502
3558
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
280
1652
1.86
17.67
3.1
2.5
%
19.4
23.1
4.37
235
1406
(3018095) Leukocytes [#/volume] in Urine
597
4341
1.63
17.61
5.4
3.7
e6/l
170.3
109.8
0.48
471
3149
(36304419) Bacteria [Presence] in Urine
480
3304
1.67
17.61
4.6
3.1
—
—
—
0
0
(3009261) Glucose [Presence] in Urine by Test strip
764
5904
1.60
17.45
5.0
3.8
estimate
0.0
0.0
0.80
163
1121
(3021601) Nitrite [Presence] in Urine by Test strip
756
5838
1.60
17.24
6.5
5.1
estimate
0.0
0.0
0.50
168
1142
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
212
1151
1.98
17.17
2.8
2.1
g/l
0.2
0.2
0.04
203
1073
(40758558) Short blood count panel - Blood
442
3004
1.67
16.90
8.0
6.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
264
1551
1.85
16.82
1.3
1.2
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
142
667
2.25
16.81
11.5
10.8
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
921
7480
1.60
16.76
4.2
3.1
u/l
49.5
51.0
0.22
855
6898
(3015377) Calcium [Moles/volume] in Serum or Plasma
586
4285
1.60
16.64
4.2
3.3
mmol/l
2.3
2.4
1.75
522
3701
(3033658) Prothrombin time (PT) actual/Normal
443
3027
1.66
16.52
6.0
3.7
%
88.4
88.3
0.04
432
2944
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
685
5208
1.58
16.41
2.4
2.0
pmol/l
92.7
94.3
0.38
402
2655
(3014007) Fractional oxyhemoglobin in Arterial blood
156
769
2.15
16.38
9.9
9.9
%
94.3
93.7
1.07
156
764
(3026782) Osmolality of Urine
382
2522
1.69
16.20
3.8
2.7
mosm/kgh2o
520.4
550.9
2.21
345
2144
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
125
566
2.32
16.13
5.2
3.6
mmol/l
24.1
24.0
0.09
113
511
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
524
3753
1.61
16.09
4.1
3.1
u/l
29.6
33.6
2.26
508
3554
(3036481) Cortisol [Moles/volume] in Serum or Plasma
194
1045
1.98
16.02
2.5
2.0
nmol/l
365.7
367.9
0.05
182
945
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
246
1440
1.85
15.79
1.8
1.7
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
374
2480
1.68
15.51
1.9
1.8
nmol/l
1172.8
1190.2
0.13
301
1849
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
121
551
2.30
15.40
6.5
5.0
%
1.9
1.6
0.95
114
513
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
243
1430
1.84
15.31
1.8
1.7
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
364
2410
1.67
15.13
5.6
3.8
ng/l
318.1
412.0
0.19
287
1959
(3007930) Methemoglobin/Hemoglobin.total in Blood
119
547
2.28
14.82
6.6
5.1
%
0.9
0.9
0.47
113
510
(3048689) Calprotectin [Mass/mass] in Stool
220
1291
1.83
13.91
3.2
2.1
ug/g
206.4
145.4
1.02
166
1024
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1313
11882
1.87
13.88
26.7
14.7
mg/l
27.7
25.3
1.75
1154
9458
(3039000) Anion gap in Blood
76
293
2.68
13.81
7.9
7.1
mmol/l
11.5
11.0
0.72
70
258
(3018572) Chloride [Moles/volume] in Blood
76
293
2.68
13.81
7.9
7.1
mmol/l
105.6
105.4
0.10
70
258
(3006653) Thiamine [Moles/volume] in Blood
28
58
4.90
12.87
1.7
1.3
nmol/l
130.9
137.9
0.35
28
58
(3011397) Hemoglobin [Presence] in Urine by Test strip
389
2729
1.58
12.44
4.8
3.7
—
—
—
0
0
(3022217) INR in Platelet poor plasma by Coagulation assay
260
1654
1.69
12.32
24.3
26.0
inr
1.3
1.4
0.37
35
236
(3021960) Folate [Moles/volume] in Serum or Plasma
419
3011
1.54
11.98
1.7
1.5
nmol/l
20.3
21.2
0.53
352
2543
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
348
2399
1.59
11.94
1.2
1.2
u/ml
1.2
1.5
0.30
79
637
(3047181) Lactate [Moles/volume] in Blood
91
410
2.30
11.89
7.5
6.2
mmol/l
1.5
1.3
1.02
79
350
(3018677) aPTT in Platelet poor plasma by Coagulation assay
287
1893
1.64
11.79
1.9
2.1
s
30.2
29.9
0.28
277
1835
(3006217) Methemoglobin/Hemoglobin.total in Arterial blood
143
770
1.95
11.74
10.6
9.8
%
0.7
0.7
0.54
143
765
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
99
468
2.19
11.53
3.9
3.3
u/ml
269.6
2649.4
0.58
86
404
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
509
3838
1.49
11.50
2.9
3.0
ng/l
1426.2
1548.0
0.24
434
3300
(40761535) Cells panel - Urine sediment
175
1016
1.82
11.38
4.1
3.3
—
—
—
0
0
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
94
438
2.22
11.35
3.3
2.6
u/ml
0.3
0.4
1.28
57
249
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
307
2080
1.60
11.26
3.6
2.7
e6/l
1.1
1.1
0.06
177
1201
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
138
745
1.94
11.24
1.5
1.4
—
—
—
0
0
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
121
628
2.01
11.04
10.8
10.5
mmol/l
24.6
24.4
0.23
113
592
(3009343) pH of Capillary blood
145
802
1.89
10.98
5.4
3.8
ph
7.4
7.4
0.58
27
112
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1046
9124
1.49
10.85
4.2
4.0
pmol/l
14.7
14.9
2.16
957
8226
(3020891) Body temperature
101
495
2.12
10.75
7.0
4.6
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
431
3179
1.50
10.70
2.8
2.6
umol/l
4341.3
7505.6
0.68
375
2728
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
146
817
1.87
10.67
5.4
3.8
kpa
5.2
5.2
0.00
139
749
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
577
4511
1.45
10.65
5.3
4.0
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
433
3202
1.50
10.60
5.6
4.0
estimate
0.0
0.0
0.69
162
1098
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
217
1368
1.69
10.55
4.9
3.4
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
138
771
1.87
10.13
5.3
3.8
mmol/l
2.4
2.0
0.47
103
580
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
286
1952
1.58
10.07
4.0
2.9
e6/l
3.0
2.2
0.71
162
1078
(3013512) EKG study
486
3711
1.46
10.00
4.8
4.0
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
625
5018
1.42
9.73
3.1
2.2
nmol/l
76.5
78.7
1.14
575
4440
(3000494) Fungus identified in Specimen by Culture
217
1410
1.63
9.34
1.7
1.4
—
—
—
0
0
(3019550) Sodium [Moles/volume] in Serum or Plasma
1337
12437
1.71
9.28
30.8
17.2
mmol/l
139.4
139.6
3.11
1315
12091
(3003327) Ova and parasites identified in Stool by Light microscopy
71
321
2.27
9.25
1.9
1.7
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
379
2795
1.48
9.20
1.9
1.7
pmol/l
68615842.8
25210141.6
0.42
325
2265
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1207
10974
1.52
9.09
5.2
4.8
mu/l
1.9
2.1
0.89
1106
9947
(3044889) 12 lead EKG panel
980
8571
1.42
9.02
4.7
3.9
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
182
1142
1.68
8.96
4.2
3.0
ng/l
231.7
212.0
0.19
165
1052
(3018405) Lactate [Moles/volume] in Arterial blood
89
447
2.05
8.91
5.1
4.0
mmol/l
1.4
1.4
0.17
89
441
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
176
1098
1.68
8.85
2.4
2.5
ug/l
6.5
7.1
0.19
151
961
(3023103) Potassium [Moles/volume] in Serum or Plasma
1337
12471
1.69
8.75
30.9
17.4
mmol/l
4.0
4.0
0.08
1314
12109
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
117
652
1.86
8.67
2.8
2.4
—
—
—
0
0
(3010517) Carboxyhemoglobin/Hemoglobin.total in Venous blood
109
596
1.89
8.56
3.4
2.3
%
1.4
1.2
1.37
109
591
(3049717) Cytology report of Urine Cyto stain
97
512
1.96
8.46
3.0
2.7
—
—
—
0
0
(40767503) Oxygen content in Capillary blood by calculation
63
282
2.29
8.42
2.7
2.6
%
15.4
16.0
0.38
33
142
(3021589) Normoblasts [#/volume] in Blood
648
5327
1.38
8.40
14.5
9.6
e9/l
0.0
0.0
0.43
543
4358
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
158
973
1.70
8.34
4.2
2.7
ml/min/173m2
63.4
63.4
0.00
75
415
(3007164) IgA [Mass/volume] in Serum or Plasma
294
2110
1.49
8.06
1.4
1.5
g/l
2.5
2.5
0.28
174
1241
(3005895) Myoglobin [Mass/volume] in Serum or Plasma
87
457
1.96
7.72
2.0
2.2
ug/l
458.1
485.4
0.05
82
428
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
211
1427
1.56
7.62
3.8
4.0
u/l
243.5
252.2
0.32
202
1348
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
51
219
2.38
7.52
4.8
4.8
iu/ml
2653.0
919.0
—
7
31
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
159
1008
1.65
7.51
5.2
3.5
ng/l
116.1
89.3
1.28
137
875
(3016244) Insulin [Units/volume] in Serum or Plasma
19
45
4.26
7.48
2.3
3.4
mu/l
21.7
22.6
0.03
19
45
(40760892) CBC W Ordered Manual Differential panel - Blood
341
2554
1.43
7.44
5.5
4.5
—
—
—
0
0
(1616796) Gas panel - Central venous blood
61
286
2.18
7.33
4.3
4.0
—
—
—
0
0
(3012501) Base excess in Blood by calculation
63
300
2.15
7.29
7.4
4.9
mmol/l
2.4
2.8
0.43
45
210
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
57
262
2.22
7.20
1.6
1.4
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
407
3166
1.39
7.11
1.8
1.6
mmol/l
1.5
1.4
2.07
331
2627
(3019150) Specific gravity of Urine by Refractometry
342
2582
1.42
7.10
5.3
4.0
kg/l
1.0
1.0
0.80
44
384
(3022313) Gas panel - Capillary blood
101
574
1.81
7.06
5.9
3.9
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
36
135
2.71
7.02
1.2
1.3
nmol/l
—
—
—
0
0
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
190
1279
1.56
6.99
1.7
1.5
—
—
—
0
0
(3004529) Oxygen [Partial pressure] adjusted to patient's actual temperature in Venous blood
102
584
1.80
6.96
4.8
3.7
%
49.4
48.2
0.19
102
575
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
269
1950
1.46
6.94
1.3
1.3
iu/ml
31.6
35.6
0.22
89
621
(3010015) Selenium [Moles/volume] in Serum or Plasma
11
8
13.84
6.89
3.5
1.5
umol/l
1.2
1.3
—
11
8
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
70
356
2.01
6.83
1.7
1.7
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
64
317
2.06
6.71
3.9
3.6
kpa
8.1
8.1
0.02
59
290
(40768804) Tissue Pathology biopsy report
573
4738
1.34
6.71
2.3
2.1
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
1312
12327
1.53
6.63
25.6
14.1
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
222
1567
1.49
6.53
1.8
1.6
—
—
—
0
0
(3015235) Bicarbonate [Moles/volume] in Capillary blood
67
343
2.00
6.43
4.0
3.2
mmol/l
24.3
25.1
0.57
60
292
(3009508) Creatinine [Moles/volume] in Urine
484
3924
1.35
6.40
3.6
3.2
mmol/l
7.3
7.2
0.05
402
3281
(3052851) Hemolysis interference index of Serum or Plasma
71
372
1.95
6.39
3.9
3.4
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
55
263
2.13
6.33
4.0
2.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
204
1425
1.50
6.31
2.2
2.5
%
1.9
1.8
0.63
179
1263
(3000570) Elastase.pancreatic [Mass/mass] in Stool
66
339
1.99
6.29
1.7
1.4
ug/g
265.7
272.2
0.10
44
201
(3020682) Albumin/Creatinine [Ratio] in Urine
491
4003
1.34
6.22
4.4
4.0
mg/mmol
10.6
8.6
0.53
325
2515
(3012516) Albumin [Mass/volume] in Urine
464
3763
1.34
6.06
3.6
3.2
mg/l
364.0
264.1
0.18
313
2367
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
319
2440
1.39
6.05
4.3
2.9
mmol/l
2.5
2.5
0.31
278
2133
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
51
242
2.15
6.00
4.6
3.5
%
55.8
58.5
0.66
51
242
(3041096) Erythrocytes [Presence] in Urine by Automated
398
3158
1.35
6.00
4.4
3.6
—
—
—
0
0
(3010421) pH of Blood
68
360
1.93
5.95
7.0
4.6
ph
7.4
7.4
0.46
63
297
(40761536) Microorganisms panel - Urine sediment
156
1043
1.55
5.91
5.5
4.0
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
55
271
2.07
5.88
2.6
2.3
g/l
123.7
128.6
0.60
39
204
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
22
70
3.17
5.75
1.4
1.2
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
22
70
3.17
5.75
1.4
1.2
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
762
6651
1.30
5.75
3.0
2.7
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
161
1091
1.53
5.74
1.7
1.5
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
208
1491
1.46
5.64
1.3
1.3
titre
581.1
553.8
0.06
36
317
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1337
12692
1.51
5.57
15.0
10.4
u/l
24.7
25.5
1.06
1296
12191
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
85
495
1.76
5.53
6.1
4.2
mmol/l
25.3
24.9
0.65
80
457
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
54
271
2.03
5.52
1.5
1.3
—
—
—
0
0
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
54
271
2.03
5.52
1.5
1.3
—
—
—
0
0
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
92
549
1.72
5.49
2.2
1.9
ug/l
1.0
2.0
0.94
82
488
(3017181) Myelocytes/100 leukocytes in Blood
154
1047
1.52
5.42
4.4
4.1
%
1.0
0.9
0.13
57
307
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
43
200
2.18
5.35
1.3
1.3
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
156
1067
1.52
5.34
2.2
2.6
g/l
66.3
66.4
0.06
144
975
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1196
11165
1.36
5.19
7.1
6.0
mmol/mol
41.2
40.3
2.57
1100
10217
(3023520) Reticulocytes [#/volume] in Blood
154
1062
1.50
5.07
2.5
2.6
e9/l
73.9
69.6
0.78
118
808
(3002256) Pathology report gross observation
211
1548
1.42
5.05
1.4
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
140
950
1.52
4.98
4.4
3.9
%
0.6
0.7
0.10
39
220
(36660697) Celiac disease serology panel - Serum
127
846
1.55
4.91
1.2
1.2
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
121
798
1.56
4.89
1.8
1.6
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
49
249
2.00
4.87
3.7
2.9
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
14
37
3.81
4.81
1.1
1.1
—
—
—
0
0
(3005719) IgG [Mass/volume] in Serum or Plasma
127
851
1.54
4.79
2.5
2.8
g/l
9.9
10.7
1.43
119
770
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
43
211
2.07
4.71
1.7
2.0
u/l
1548.8
3755.9
—
8
84
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
93
583
1.63
4.65
1.5
1.8
g/l
1.6
1.6
0.30
86
508
(3034860) Kappa light chains.free [Mass/volume] in Serum
71
415
1.75
4.60
1.5
3.3
mg/l
44.3
62.6
0.56
57
335
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
71
415
1.75
4.60
1.5
3.3
mg/l
31.5
49.3
1.19
57
334
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
29
122
2.40
4.58
2.8
2.8
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
155
1094
1.47
4.56
6.4
3.9
mmol/l
1.2
1.2
0.30
140
935
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
22
82
2.71
4.42
1.6
1.3
—
—
—
0
0
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
243
1875
1.35
4.28
1.2
1.2
u/ml
6.9
12.8
0.77
85
719
(3021440) Promyelocytes/100 leukocytes in Blood
141
993
1.46
4.21
4.5
4.1
%
0.2
0.1
0.61
49
280
(4035726)
147
1049
1.45
4.10
1.5
1.4
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
1136
10634
1.28
4.09
26.6
16.0
%
38.9
39.1
0.47
730
7201
(3037121) Protein [Mass/volume] in Urine
71
430
1.68
4.09
5.6
3.1
g/l
0.3
0.3
0.33
44
159
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
12
32
3.77
4.09
1.2
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
51
281
1.84
4.05
1.5
1.6
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
33
156
2.14
4.01
1.8
1.6
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
1053
9782
1.26
3.95
30.8
18.0
%
14.1
13.8
8.10
1038
9532
(3025159) Blasts/100 leukocytes in Blood
133
939
1.46
3.93
4.5
4.1
%
0.3
0.5
0.10
42
232
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
35
171
2.07
3.92
1.2
1.4
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
103
691
1.53
3.90
1.5
1.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
81
514
1.61
3.90
2.1
1.9
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
21
82
2.58
3.89
1.6
1.3
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
52
293
1.80
3.86
1.5
1.6
—
—
—
0
0
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
159
2.10
3.84
1.2
1.5
—
—
—
0
0
(3003181) Sodium [Moles/volume] in Urine
43
229
1.90
3.80
3.4
1.3
mmol/l
60.2
63.6
0.23
30
190
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
30
141
2.15
3.72
1.2
1.3
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1231
11686
1.30
3.70
5.4
4.7
mmol/l
6.1
6.0
1.49
1130
10518
(3045424) Erythrocytes [Presence] in Urine
34
169
2.04
3.66
1.4
1.3
—
—
—
0
0
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
57
336
1.72
3.65
1.3
1.1
—
—
—
0
0
(3019225) pH of Specimen
167
1252
1.38
3.54
4.7
4.2
—
—
—
0
0
(3006245) CD3-CD19+ cells/100 cells in Blood
13
41
3.19
3.50
2.2
2.6
%
13.0
11.0
0.22
13
34
(3014765) Yersinia sp identified in Stool by Organism specific culture
57
341
1.70
3.47
1.3
1.1
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
37
195
1.92
3.40
1.2
1.4
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
17
64
2.68
3.40
1.7
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
17
64
2.68
3.40
1.7
1.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
53
314
1.71
3.36
1.5
3.7
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
57
345
1.68
3.34
1.3
1.2
—
—
—
0
0
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
32
164
1.97
3.20
1.1
1.0
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
24
110
2.20
3.20
1.1
1.2
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
30
152
1.99
3.11
1.3
1.5
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
103
727
1.45
3.09
1.8
1.7
—
—
—
0
0
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
12
39
3.09
3.09
2.2
2.4
%
32.0
25.5
0.80
12
34
(3037756) Immunofixation for Serum or Plasma
48
284
1.71
3.08
1.2
1.7
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
34
181
1.90
3.06
1.2
1.6
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
30
153
1.98
3.06
1.6
2.5
mg/l
68.8
25.0
—
5
44
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
43
247
1.76
3.05
1.3
1.6
—
—
—
0
0
(3024731) MCV [Entitic volume]
1361
13175
1.37
3.04
37.6
21.6
fl
91.1
91.3
0.83
1346
12943
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
21
93
2.28
3.04
1.2
1.4
—
—
—
0
0
(3035941) MCH [Entitic mass]
1361
13176
1.37
3.03
37.6
21.6
pg
30.1
30.4
4.73
1346
12941
(3026361) Erythrocytes [#/volume] in Blood
1361
13177
1.37
3.02
37.8
21.7
e12/l
4.4
4.4
5.66
1332
12749
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
39
219
1.80
2.99
5.3
2.9
—
—
—
0
0
(3010813) Leukocytes [#/volume] in Blood
1361
13180
1.37
2.98
37.8
21.7
e9/l
7.2
6.8
4.84
1329
12749
(3000963) Hemoglobin [Mass/volume] in Blood
1361
13180
1.37
2.98
38.2
21.8
g/l
130.3
134.0
15.05
1347
12952
(3042517) Benzodiazepines panel - Urine
5
5
10.03
2.98
1.2
3.4
—
—
—
0
0
(3003101) Alpha 1 antitrypsin [Mass/mass] in Stool
5
5
10.03
2.98
1.8
1.4
ug/g
76.2
172.8
—
5
5
(3051651) Icteric interference index of Serum or Plasma
17
69
2.48
2.96
4.9
3.8
—
—
—
0
0
(3007461) Platelets [#/volume] in Blood
1360
13172
1.36
2.95
37.8
21.7
e9/l
252.3
248.0
1.50
1333
12793
(3004588) Protein electrophoresis panel - Serum or Plasma
121
889
1.39
2.92
1.5
2.3
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
66
430
1.56
2.92
2.6
2.7
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
23
108
2.15
2.91
1.3
1.3
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
194
1537
1.30
2.85
10.9
7.0
—
—
—
0
0
(3014148) Varicella zoster virus Ab [Titer] in Serum
21
97
2.18
2.77
1.1
1.2
—
—
—
0
0
(3017354) Segmented neutrophils/100 leukocytes in Blood
25
124
2.03
2.77
2.5
3.6
%
53.9
56.4
0.20
18
82
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
111
812
1.40
2.76
2.0
1.8
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
5
6
8.36
2.75
1.0
1.2
—
—
—
0
0
(3023183) Ammonium ion [Moles/volume] in Plasma
45
271
1.68
2.74
2.2
2.5
umol/l
32.1
34.4
0.27
39
232
(3025468) Yersinia sp identified in Specimen by Organism specific culture
29
153
1.91
2.71
2.1
1.5
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
36
204
1.78
2.71
4.4
3.6
%
2.4
1.5
0.35
29
162
(4010399)
115
851
1.38
2.68
1.5
1.4
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
30
161
1.88
2.67
1.1
1.1
—
—
—
0
0
(3000492) Spirometry study
131
992
1.35
2.65
1.5
1.4
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
39
228
1.73
2.65
1.2
1.4
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
22
106
2.09
2.63
1.2
1.6
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
29
155
1.89
2.62
2.2
1.5
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
29
155
1.89
2.62
2.2
1.5
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
92
658
1.42
2.61
3.6
3.5
pmol/l
4.3
4.4
0.47
85
575
(3023323) Follitropin [Units/volume] in Serum or Plasma
58
378
1.56
2.59
1.6
1.3
iu/l
26.6
30.3
0.35
49
321
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
9
25
3.62
2.57
1.0
1.2
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
11
5.47
2.54
5.2
5.5
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
10
33
3.04
2.53
1.2
1.2
—
—
—
0
0
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
17
75
2.28
2.51
1.5
1.8
—
—
—
0
0
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
54
349
1.57
2.51
1.7
1.6
iu/ml
0.0
2.2
0.52
18
66
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
16
69
2.33
2.48
1.1
1.6
—
—
—
0
0
(1002224) Polysomnography panel
62
416
1.51
2.45
1.1
1.1
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
31
174
1.80
2.43
1.1
1.1
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
32
182
1.77
2.40
1.5
1.2
—
—
—
0
0
(3025927) Herpes simplex virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
6
12
5.02
2.40
1.0
1.4
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
28
153
1.85
2.39
2.1
1.5
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
58
387
1.52
2.36
2.2
1.8
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
13
52
2.51
2.36
1.0
1.3
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
28
154
1.83
2.35
2.1
1.4
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
27
147
1.85
2.33
1.1
1.1
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
92
673
1.39
2.33
1.9
1.8
g/l
1.8
1.5
0.39
87
610
(3026389) Candida sp identified in Specimen by Organism specific culture
26
140
1.87
2.32
1.8
1.4
—
—
—
0
0
(3038177) Helicobacter pylori Ab [Presence] in Serum
29
162
1.81
2.32
1.1
1.2
—
—
—
0
0
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
28
155
1.82
2.30
2.2
1.4
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
39
239
1.65
2.27
1.1
1.2
—
33.3
—
0
6
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1176
11273
1.20
2.25
23.0
13.9
ml/min/173m2
77.9
77.6
0.15
1035
9277
(3019473) Protein [Mass/volume] in Cerebral spinal fluid
45
287
1.59
2.24
1.1
1.4
mg/l
493.6
500.7
0.04
40
269
(3024891) Influenza virus A+B Ag [Presence] in Specimen
46
295
1.58
2.24
1.2
1.2
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
14
60
2.35
2.22
1.4
1.4
ug/l
7.5
9.7
0.38
14
50
(3030366) Cystatin C [Mass/volume] in Serum or Plasma
50
328
1.54
2.21
6.9
3.6
mg/l
1.8
1.6
0.51
43
297
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
36
218
1.67
2.20
1.5
1.6
—
—
—
0
0
(3043410) Blood group antigens tested for on Red Blood Cells
11
42
2.63
2.18
3.3
2.4
—
—
—
0
0
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
26
144
1.82
2.15
1.2
1.7
—
—
—
0
0
(3035320) C reactive protein [Mass/volume] in Body fluid
17
81
2.11
2.13
3.4
2.5
—
—
—
0
0
(3020191) Ethanol [Moles/volume] in Serum or Plasma
17
81
2.11
2.13
1.2
1.6
promille
1.3
1.2
0.20
12
61
(3022621) pH of Urine by Test strip
109
834
1.33
2.10
3.5
3.2
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
33
198
1.68
2.10
2.0
1.4
—
—
—
0
0
(44806118)
23
124
1.87
2.07
1.2
1.5
—
—
—
0
0
(44790047)
23
124
1.87
2.07
1.2
1.5
—
—
—
0
0
(44790048)
23
124
1.87
2.07
1.2
1.5
—
—
—
0
0
(44790049)
23
124
1.87
2.07
1.2
1.5
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
150
1202
1.28
2.06
1.7
1.6
—
—
—
0
0
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
7
20
3.51
2.05
1.0
1.0
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
99
750
1.34
2.05
1.3
1.3
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
15
69
2.19
2.05
1.1
1.6
—
—
—
0
0
(3036489) Thrombin time
60
417
1.46
2.04
2.1
2.1
s
21.4
21.6
0.14
54
374
(40768443) Skin Pathology biopsy report
73
527
1.40
2.03
1.2
1.2
—
—
—
0
0
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
16
76
2.12
2.02
2.1
1.7
u/l
5.6
7.7
—
9
43
(3021236) Streptolysin O Ab [Units/volume] in Serum or Plasma
12
50
2.41
2.02
1.1
1.2
iu/ml
79.8
235.2
1.82
12
50
(3042733) HLA Ab [Presence] in Serum
8
26
3.09
2.01
4.8
3.9
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
14
63
2.23
2.01
1.1
1.3
—
—
—
0
0
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
10
38
2.64
2.01
3.2
2.7
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
13
57
2.29
1.98
1.3
1.0
—
—
—
0
0
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
13
57
2.29
1.98
1.3
1.0
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
27
156
1.74
1.97
1.4
1.5
g/l
0.7
0.7
0.03
22
124
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
16
77
2.09
1.97
3.6
2.0
e6/l
852.6
682.8
—
5
31
(3051611) Lipemic interference index of Serum or Plasma
24
134
1.80
1.96
4.3
3.5
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
5
11
4.56
1.94
1.4
1.4
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
5
11
4.56
1.94
1.0
1.2
—
—
—
0
0
(3037677) Mycoplasma pneumoniae IgM Ab [Titer] in Cerebral spinal fluid
9
33
2.74
1.93
1.0
1.2
—
—
—
0
0
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
57
398
1.45
1.91
1.6
1.6
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
16
78
2.06
1.91
2.5
2.0
%
73.9
72.2
0.23
16
72
(3020044) Glucose [Moles/volume] in Cerebral spinal fluid
40
259
1.56
1.91
1.1
1.3
mmol/l
4.1
3.9
0.38
35
242
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
17
85
2.01
1.90
1.1
1.5
—
—
—
0
0
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
9
34
2.66
1.86
3.6
3.4
—
—
—
0
0
(3002823) Mycoplasma pneumoniae IgG Ab [Units/volume] in Cerebral spinal fluid
9
34
2.66
1.86
1.0
1.1
—
—
—
0
0
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
72
2.09
1.86
2.6
2.1
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
15
72
2.09
1.86
3.0
3.6
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
13
59
2.21
1.84
1.4
1.1
—
—
—
0
0
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
65
469
1.40
1.84
1.3
2.1
g/l
3.0
3.1
0.45
48
378
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
10
40
2.51
1.83
1.0
1.1
miu/ml
1063.7
1660.1
—
10
40
(3003338) MCHC [Mass/volume]
1028
9806
1.15
1.83
33.3
19.2
g/l
330.0
332.0
9.32
1021
9722
(3028009) Chlamydia trachomatis IgG Ab [Units/volume] in Serum
5
12
4.18
1.82
1.2
1.0
—
—
—
0
0
(3047166) Epithelial cells [#/area] in Urine sediment by Automated count
5
12
4.18
1.82
1.8
3.6
u/field
0.4
0.4
—
5
12
(3005322) IgE [Units/volume] in Serum or Plasma
89
677
1.33
1.82
1.3
1.2
u/ml
136.9
195.7
1.04
82
614
(3011412) CD3 cells [#/volume] in Blood
19
101
1.89
1.81
2.8
2.1
e9/l
1.8
1.1
1.63
13
60
(3008757) Leukocyte morphology finding [Identifier] in Blood
24
138
1.75
1.80
2.5
4.2
—
—
—
0
0
(3024932) HLA-DR beta [Type]
8
29
2.77
1.79
1.3
1.1
—
—
—
0
0
(3024471) HLA-A [Type]
8
29
2.77
1.79
1.0
1.0
—
—
—
0
0
(4024509)
21
116
1.82
1.79
1.7
1.6
—
—
—
0
0
(3006462) Nitrate [Presence] in Urine
11
47
2.35
1.78
4.4
3.8
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
20
109
1.85
1.77
2.4
2.4
u/field
4.4
0.7
1.83
12
40
(4211845)
12
54
2.23
1.74
4.2
3.6
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
9
36
2.51
1.74
1.0
1.3
—
—
—
0
0
(4062490)
19
103
1.86
1.72
1.4
1.2
—
—
—
0
0
(3014271) Vancomycin [Susceptibility]
14
68
2.07
1.70
2.8
3.1
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
502
1.37
1.70
1.3
2.1
g/l
4.1
3.8
1.21
48
370
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
503
1.37
1.68
1.3
2.1
g/l
7.5
7.5
0.04
52
383
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
68
503
1.37
1.68
1.3
2.1
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
19
104
1.84
1.67
2.3
1.0
—
—
—
0
0
(4034850)
53
376
1.42
1.67
12.3
10.6
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
71
530
1.36
1.66
1.5
1.3
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
100
785
1.29
1.66
3.2
2.9
e9/l
4.1
4.1
0.11
77
597
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
22
127
1.74
1.64
1.8
1.6
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
44
302
1.47
1.64
2.0
1.7
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
25
150
1.68
1.64
1.0
1.0
u/ml
0.8
2.1
—
8
57
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
5
14
3.58
1.61
2.2
2.9
umol/l
17.6
18.3
—
5
14
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
12
56
2.15
1.61
2.3
2.7
u/ml
801.8
1583.1
0.77
12
56
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
42
287
1.48
1.61
1.7
1.8
iu/l
3.1
4.9
0.96
11
101
(3035637) Corticotropin [Mass/volume] in Plasma
22
128
1.73
1.60
2.7
1.7
—
—
—
0
0
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
38
255
1.50
1.59
1.2
1.4
nmol/l
0.9
0.8
0.22
32
211
(3016888) Borrelia burgdorferi IgG Ab [Units/volume] in Serum
87
675
1.31
1.58
1.3
1.3
au/ml
47.2
43.0
—
5
27
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
195
1661
1.20
1.57
1.5
1.5
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1210
11733
1.16
1.53
4.9
4.5
mmol/l
4.4
4.6
8.43
1114
10737
(3009466) Valproate [Moles/volume] in Serum or Plasma
27
169
1.61
1.52
3.4
5.0
umol/l
343.0
361.1
0.21
22
150
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
15
3.34
1.52
3.2
1.4
umol/l
59.2
35.5
—
5
15
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
50
358
1.41
1.52
1.3
1.8
g/l
0.0
0.0
0.00
45
330
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
41
283
1.46
1.51
1.4
1.3
—
—
—
0
0
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
21
2.86
1.50
5.0
6.7
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1235
12001
1.17
1.49
5.4
5.0
mmol/l
2.5
2.7
8.68
1131
10911
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
58
428
1.37
1.48
1.5
2.0
g/l
0.2
1.2
2.85
51
371
(42868421) Varicella zoster virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
9
37
2.44
1.48
1.0
1.2
—
—
—
0
0
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
52
379
1.39
1.44
1.3
1.8
g/l
0.0
0.0
0.50
47
346
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
50
362
1.39
1.44
1.3
1.8
g/l
0.0
0.0
0.00
45
331
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
5
16
3.13
1.44
5.8
7.9
—
—
—
0
0
(3037534) Parathyrin related protein [Mass/volume] in Serum or Plasma
5
16
3.13
1.44
1.4
1.4
ng/l
88.0
104.5
—
5
16
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
6
22
2.73
1.43
1.0
1.0
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
45
320
1.42
1.43
3.0
2.2
ug/min
169.7
111.2
0.28
26
191
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
44
314
1.41
1.38
2.0
1.6
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1197
11623
1.15
1.38
4.8
4.4
mmol/l
1.4
1.5
6.05
1097
10558
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
20
119
1.69
1.38
1.9
1.6
—
—
—
0
0
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
28
182
1.55
1.37
1.6
1.4
u/ml
113.2
110.9
—
9
37
(3015616) Isopropanol [Moles/volume] in Serum or Plasma
5
17
2.95
1.36
1.0
1.6
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
26
167
1.57
1.35
2.5
2.4
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
17
98
1.74
1.31
1.9
1.5
u/ml
16.0
26.4
—
5
17
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
6
24
2.51
1.30
5.0
6.8
—
—
—
0
0
(3043525) Herpes simplex virus Ab [Presence] in Cerebral spinal fluid
5
18
2.78
1.28
1.0
1.4
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
17
99
1.73
1.27
3.1
2.4
—
—
—
0
0
(4306422)
23
146
1.58
1.26
1.3
1.2
—
—
—
0
0
(3047007) Chlamydophila sp Ab [Presence] in Serum
23
147
1.57
1.23
1.0
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
29
197
1.48
1.19
1.5
1.2
—
—
—
0
0
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
15
86
1.75
1.19
1.3
1.2
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
8
38
2.11
1.18
1.8
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
19
117
1.63
1.18
1.1
2.5
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
12
64
1.88
1.18
1.1
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
21
133
1.59
1.17
1.5
1.3
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
16
94
1.71
1.17
1.4
1.2
—
—
—
0
0
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
35
248
1.42
1.17
1.4
1.4
e6/l
523.0
1053.3
0.43
26
206
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
35
248
1.42
1.17
1.3
1.4
e6/l
26.8
23.4
0.05
24
198
(3015171) Extractable nuclear Ab [Units/volume] in Serum
55
421
1.32
1.16
1.2
1.2
u/ml
5.5
0.9
—
7
36
(4015189)
0
33
0.00
1.16
0.0
2.9
—
—
—
0
0
(3023365) Varicella zoster virus Ab [Titer] in Cerebral spinal fluid
5
20
2.50
1.15
1.0
1.3
—
—
—
0
0
(3011648) Oxygen content in Venous blood
16
95
1.69
1.14
2.4
1.7
%
9.7
10.7
0.47
16
95
(21494755) Public health laboratory ask at order entry panel
63
797
0.78
1.13
1.3
1.4
—
—
—
0
0
(3000012) Reticulocyte production index
12
65
1.85
1.13
1.5
1.7
—
—
—
0
0
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
39
284
1.38
1.13
1.2
1.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
29
200
1.46
1.12
1.6
1.4
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
11
58
1.90
1.12
1.7
1.3
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
13
73
1.79
1.11
2.5
1.5
g/l
0.9
1.0
0.42
13
73
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
140
1200
1.18
1.10
1.9
1.8
%
1.5
1.5
0.15
117
1044
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
24
160
1.51
1.09
1.3
1.2
u/ml
2.3
2.4
0.03
15
49
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
52
399
1.31
1.09
1.3
1.7
g/l
37.9
37.2
0.35
46
346
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
5
21
2.39
1.09
1.2
1.0
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
7
32
2.19
1.08
2.9
2.3
—
—
—
0
0
(3015916) Alpha-1-Fetoprotein [Units/volume] in Serum or Plasma
24
161
1.50
1.07
1.8
2.2
u/ml
8.4
30.1
0.42
24
153
(3017569) Oxygen content in Arterial blood
11
60
1.84
1.03
3.6
3.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
7
34
2.06
1.03
2.0
1.5
—
—
—
0
0
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
202
2267
0.87
1.02
3.1
3.1
ug/l
0.6
0.8
2.35
143
1553
(3014051) Protein [Presence] in Urine by Test strip
39
290
1.35
1.02
2.6
2.2
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
60
476
1.27
1.00
1.3
2.1
g/l
10.4
10.3
0.03
50
409
(3042975) Streptococcus sp identified in Isolate by Organism specific culture
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(40761849) Varicella zoster virus IgG Ab [Units/volume] in Cerebral spinal fluid by Immunoassay
7
35
2.00
1.00
1.0
1.1
—
—
—
0
0
(4268621)
17
107
1.60
0.99
2.6
2.3
—
—
—
0
0
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
23
156
1.48
0.98
1.3
1.2
u/ml
3.8
5.4
0.41
12
69
(3028679) Herpes simplex virus Ab [Presence] in Serum
9
49
1.84
0.98
1.2
1.1
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
5
23
2.18
0.98
1.0
1.1
—
—
—
0
0
(3020650) Glucose [Presence] in Urine
5
23
2.18
0.98
1.8
1.6
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
67
822
0.81
0.96
1.7
1.7
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
18
117
1.55
0.94
1.0
1.1
—
—
—
0
0
(40758310) Human epididymis protein 4 [Moles/volume] in Serum or Plasma
36
269
1.35
0.93
1.3
1.4
pmol/l
261.2
246.1
0.03
36
263
(3017704) Immunofixation for Urine
13
78
1.67
0.91
1.1
1.7
—
—
—
0
0
(3009871) Measles virus Ab [Titer] in Serum
6
28
2.15
0.91
1.5
1.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
6
28
2.15
0.91
1.0
1.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
39
296
1.33
0.91
3.4
3.2
nmol/l
0.8
0.8
0.31
28
235
(3020629) Protein S Free Ag actual/normal in Platelet poor plasma by Immunoassay
17
110
1.55
0.90
1.1
1.1
%
101.5
95.2
0.55
17
105
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
66
538
1.24
0.90
2.3
1.9
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
61
493
1.25
0.89
2.3
1.8
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
18
266
0.67
0.89
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
173
1542
1.14
0.85
4.2
4.6
%
32.3
33.2
0.47
119
1013
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
6
31
1.94
0.84
1.2
1.2
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
30
222
1.36
0.84
1.5
1.6
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
28
205
1.37
0.83
2.0
1.5
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
26
188
1.39
0.83
1.6
1.2
u/ml
304.8
273.0
0.15
17
114
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
11
65
1.70
0.82
1.0
1.2
—
—
—
0
0
(3012565) Volume of 24 hour Urine
11
65
1.70
0.82
1.4
2.9
ml
1195.5
1895.6
2.33
11
58
(4198724)
6
32
1.88
0.82
1.0
1.4
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
6
32
1.88
0.82
1.5
2.0
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
16
105
1.53
0.81
1.2
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
34
259
1.32
0.80
1.6
1.9
—
—
—
0
0
(3004451) EKG impression Narrative
10
58
1.73
0.79
1.9
1.2
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
10
58
1.73
0.79
3.0
3.7
—
—
—
0
0
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
25
339
0.73
0.79
1.6
1.4
—
—
—
0
0
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
24
0.00
0.79
0.0
1.0
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
8
48
1.67
0.78
1.1
1.2
—
—
—
0
0
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
15
98
1.54
0.78
1.6
1.4
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
34
260
1.31
0.78
1.6
1.9
—
—
—
0
0
(3025130) Human papilloma virus identified in Specimen
7
123
0.57
0.78
2.1
1.8
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
22
157
1.41
0.77
1.5
1.4
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
6
34
1.77
0.76
1.3
1.4
—
—
—
0
0
(42868415) European tick borne encephalitis virus IgM Ab [Presence] in Cerebral spinal fluid by Immunoassay
6
34
1.77
0.76
1.0
1.2
—
—
—
0
0
(3005570) Glucose [Moles/volume] in Urine
19
132
1.45
0.76
2.2
2.0
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
10
59
1.70
0.76
1.0
1.2
—
—
—
0
0
(4146454)
20
141
1.42
0.74
2.9
2.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
36
280
1.29
0.74
1.2
1.1
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
5
24
2.09
0.74
1.2
1.5
—
—
—
0
0
(3002067) Lambda light chains [Mass/time] in 24 hour Urine
5
24
2.09
0.74
1.4
4.0
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
9
54
1.67
0.74
1.1
1.2
—
—
—
0
0
(3008898) HLA-B27 [Presence]
44
352
1.26
0.73
1.0
1.1
—
—
—
0
0
(3048879) Bone marrow aspiration report
7
38
1.85
0.73
1.7
1.8
—
—
—
0
0
(3000330) Specific gravity of Urine by Test strip
80
683
1.18
0.72
4.4
3.7
—
—
—
0
0
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
13
85
1.53
0.69
1.2
1.1
—
—
—
0
0
(42868417) European tick borne encephalitis virus IgG Ab [Presence] in Serum by Immunoassay
5
27
1.85
0.68
1.0
1.2
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
5
27
1.85
0.68
1.8
3.1
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
20
144
1.39
0.68
1.0
1.0
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1145
11229
1.08
0.66
4.3
4.0
mmol/l
1.4
1.3
3.29
1048
10110
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
5
28
1.79
0.66
1.0
1.2
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
33
259
1.28
0.65
1.5
1.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
23
171
1.35
0.65
2.0
1.6
—
—
—
0
0
(4027681)
10
62
1.62
0.65
1.1
1.2
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
26
198
1.32
0.64
1.7
1.9
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
39
314
1.25
0.64
4.5
3.1
mmol/l
1.7
1.6
0.07
39
304
(3017817) Protein [Mass] in Urine collected for unspecified duration
15
104
1.45
0.62
1.5
2.1
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
14
199
0.70
0.61
1.5
1.6
—
—
—
0
0
(3030862) Granulocytes [#/volume] in Cerebral spinal fluid
5
30
1.67
0.61
1.0
1.2
%
—
16.4
—
0
5
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
84
732
1.16
0.61
1.1
1.2
iu/ml
103.0
151.8
0.75
29
281
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
35
280
1.26
0.61
1.7
1.4
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
16
113
1.42
0.61
1.4
1.2
—
—
—
0
0
(3033306) Mononuclear cells/100 leukocytes in Cerebral spinal fluid
8
51
1.57
0.60
1.0
1.2
%
—
73.8
—
0
8
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
0
20
0.00
0.60
0.0
2.4
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
15
105
1.43
0.60
1.6
1.6
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
14
97
1.45
0.59
3.6
5.4
u/ml
47.3
49.1
—
5
30
(3019832) Treponema pallidum Ab [Presence] in Serum
75
651
1.16
0.58
1.8
1.5
—
—
—
0
0
(3027944) Amphetamines [Presence] in Urine
32
255
1.26
0.58
1.7
1.7
—
—
—
0
0
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
27
211
1.28
0.57
1.1
1.2
u/l
77.7
36.6
0.35
21
185
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
14
98
1.43
0.56
1.1
1.0
—
—
—
0
0
(3025018) Bordetella pertussis Ab [Titer] in Serum
8
55
1.46
0.56
1.5
1.3
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
65
1.54
0.55
1.6
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
15
107
1.41
0.55
2.3
1.4
—
—
—
0
0
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
15
107
1.41
0.55
2.3
1.4
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
15
107
1.41
0.55
2.3
1.4
—
—
—
0
0
(21494890) Protein electrophoresis panel - 24 hour Urine
17
125
1.36
0.53
1.2
2.1
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
11
74
1.49
0.53
2.1
2.1
—
—
—
0
0
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
16
117
1.37
0.52
1.3
1.4
%
17.3
31.2
—
8
71
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
18
135
1.34
0.51
4.5
4.0
—
—
—
0
0
(3019977) pH of Arterial blood
11
75
1.47
0.50
3.6
3.4
ph
7.4
7.4
—
5
27
(3030558) Cytomegalovirus DNA [Units/volume] (viral load) in Specimen by NAA with probe detection
6
41
1.47
0.50
1.3
2.2
—
63744.7
—
0
7
(3016879) Cocaine [Presence] in Urine
30
243
1.24
0.49
1.7
1.9
—
—
—
0
0
(3004915) Chlamydophila pneumoniae IgA Ab [Units/volume] in Serum
10
67
1.50
0.49
1.1
1.0
—
—
—
0
0
(3003888) Timothy IgE Ab [Units/volume] in Serum
19
145
1.31
0.49
1.2
1.1
u/ml
1.0
3.8
—
9
71
(21494434) Karyotype in Bone marrow
15
110
1.37
0.49
1.2
1.2
—
—
—
0
0
(3023421) Hepatitis B virus surface Ab [Units/volume] in Serum
30
245
1.23
0.47
1.3
1.3
miu/ml
263.5
198.3
0.43
16
115
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
23
288
0.80
0.47
1.5
1.5
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
147
1.30
0.45
1.0
1.1
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
34
283
1.21
0.45
1.5
1.2
—
—
—
0
0
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
25
201
1.25
0.45
1.1
1.1
—
—
—
0
0
(3015183) Erythrocyte sedimentation rate
7
50
1.40
0.45
1.6
1.2
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
36
302
1.20
0.44
3.3
3.1
mmol/l
7.6
7.7
0.03
36
293
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
7
51
1.37
0.44
1.1
1.4
—
—
—
0
0
(3039429) Cortisol [Moles/volume] in Saliva (oral fluid)
7
51
1.37
0.44
1.6
1.7
nmol/l
3.0
5.6
—
7
39
(3011288) Drugs identified in Urine by Screen method
22
175
1.26
0.43
4.0
2.7
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
5
31
1.61
0.43
2.8
2.2
—
—
—
0
0
(3008116) Ketones [Moles/volume] in Urine by Test strip
5
31
1.61
0.43
1.0
1.4
—
—
—
0
0
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
15
113
1.33
0.42
1.5
1.2
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
6
93
0.64
0.42
2.0
1.6
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
5
32
1.56
0.42
1.6
1.3
—
—
—
0
0
(3044242) Glucose [Moles/volume] in Arterial blood
10
70
1.43
0.41
3.4
2.6
—
—
—
0
0
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
0
15
0.00
0.41
0.0
1.4
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
15
0.00
0.41
0.0
1.7
—
7.9
—
0
8
(3013293) Extractable nuclear Ab [Presence] in Serum
0
16
0.00
0.41
0.0
1.7
—
—
—
0
0
(3013803) Aspergillus fumigatus IgG Ab [Mass/volume] in Serum
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(3010464) Parainfluenza virus 1 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3021578) Parainfluenza virus 2 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3005880) Parainfluenza virus 3 Ag [Presence] in Specimen
0
17
0.00
0.40
0.0
1.0
—
—
—
0
0
(3008401) Mugwort IgE Ab [Units/volume] in Serum
18
141
1.28
0.40
1.2
1.1
u/ml
0.3
1.5
—
7
60
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
61
541
1.13
0.39
1.0
1.1
—
—
—
0
0
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
0
19
0.00
0.39
0.0
2.5
—
—
—
0
0
(3007798) IgG/Albumin [Mass Ratio] in Cerebral spinal fluid
0
19
0.00
0.39
0.0
1.0
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
15
115
1.31
0.39
1.1
1.2
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
9
67
1.35
0.38
1.8
2.5
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
47
536
0.87
0.38
1.3
1.4
—
—
—
0
0
(1617658) Protocol used for examination of sentinel lymph nodes
13
98
1.33
0.37
1.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
5
37
1.35
0.37
1.0
1.4
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
24
198
1.22
0.36
1.7
1.4
—
—
—
0
0
(3006257) Acetylcholine receptor Ab [Moles/volume] in Serum
11
81
1.36
0.36
1.0
1.2
—
3.8
—
0
14
(3042631) Mycobacterium sp identified in Specimen
23
189
1.22
0.36
1.8
2.6
—
—
—
0
0
(44813793)
10
73
1.37
0.34
1.0
1.0
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
28
238
1.18
0.32
1.4
1.5
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
405
3919
1.05
0.32
5.0
5.0
ug/l
2.4
2.9
0.99
353
3490
(3047189) Immunofixation for 24 hour Urine
7
54
1.30
0.30
1.0
1.8
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
57
515
1.11
0.30
1.8
1.9
u/l
35.3
38.5
0.66
47
454
(3051387) C reactive protein [Mass/volume] in Capillary blood
24
282
0.85
0.30
4.1
3.5
mg/l
24.2
28.2
0.29
13
177
(3023351) European house dust mite IgE Ab [Units/volume] in Serum
19
157
1.21
0.29
1.2
1.1
u/ml
0.5
1.7
—
7
68
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
8
107
0.75
0.29
1.0
1.5
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
53
479
1.11
0.28
1.3
1.7
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
10
76
1.32
0.28
1.0
1.0
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
8
63
1.27
0.27
5.0
7.7
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
41
366
1.12
0.27
5.4
4.7
—
—
—
0
0
(40768793) Breast Pathology biopsy report
26
298
0.87
0.25
1.3
1.3
—
—
—
0
0
(42529200) Cancer Ag 15-3 [Units/volume] in Serum or Plasma by Immunoassay
14
114
1.23
0.25
5.7
3.8
u/ml
28.9
64.6
1.00
14
114
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
9
75
1.20
0.25
1.1
1.1
—
174.6
—
0
13
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
40
359
1.12
0.24
1.6
2.0
—
—
—
0
0
(40768441) Liver Pathology biopsy report
11
88
1.25
0.22
1.6
1.3
—
—
—
0
0
(40766048) U1 small nuclear ribonucleoprotein 70kD Ab [Units/volume] in Serum by Immunoassay
7
91
0.77
0.22
1.0
1.1
—
2.0
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
5
40
1.25
0.22
1.0
1.1
—
—
—
0
0
(4094501)
35
315
1.11
0.21
1.1
1.1
—
—
—
0
0
(3027955) HFE gene mutations tested for in Blood or Tissue by Molecular genetics method Nominal
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(46236287) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Pleural fluid by Immunoassay
0
11
0.00
0.21
0.0
1.3
—
4791.0
—
0
6
(3032743) Legionella sp IgG Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(21494567) Legionella sp IgM Ab [Presence] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001334) Neutrophil cytoplasmic Ab [Units/volume] in Serum
0
10
0.00
0.21
0.0
1.0
—
—
—
0
0
(3018562) Neutrophils/100 leukocytes in Cerebral spinal fluid
0
10
0.00
0.21
0.0
1.4
—
34.0
—
0
5
(3036604) Creatine kinase isoenzymes [Interpretation] in Serum or Plasma by Electrophoresis
0
12
0.00
0.21
0.0
1.3
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
5
43
1.16
0.21
1.0
1.2
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
11
89
1.24
0.21
1.2
1.2
u/ml
0.1
0.6
—
5
40
(3044009) aPTT.lupus sensitive (LA screen)
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
14
0.00
0.20
0.0
1.2
—
1036.7
—
0
5
(3050794) Legionella sp Ab [Presence] in Serum
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3044927) Protein electrophoresis panel - Urine
16
136
1.18
0.20
1.1
1.1
—
—
—
0
0
(3023420) DNA double strand Ab [Units/volume] in Serum
9
112
0.80
0.20
1.0
1.3
—
33.6
—
0
7
(3003694) ABO and Rh group [Type] in Blood
321
3127
1.03
0.19
1.4
1.4
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
52
1.15
0.19
1.2
1.0
—
—
—
0
0
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
6
53
1.13
0.18
1.2
1.4
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
13
109
1.19
0.18
1.8
1.6
—
—
—
0
0
(3045683) HLA typing for celiac disease panel - Blood or Tissue
7
59
1.19
0.18
1.0
1.0
—
—
—
0
0
(3051593) INR in Capillary blood by Coagulation assay
7
61
1.15
0.17
11.1
18.0
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
10
82
1.22
0.17
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
10
82
1.22
0.17
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
10
82
1.22
0.17
1.1
1.1
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
160
1658
0.96
0.17
1.5
1.4
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
16
139
1.15
0.16
1.3
1.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
388
3954
0.97
0.15
3.2
3.0
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
10
83
1.21
0.15
1.1
1.1
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
10
83
1.21
0.15
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
10
83
1.21
0.15
1.1
1.1
—
—
—
0
0
(4281824)
15
131
1.15
0.14
1.1
1.2
—
—
—
0
0
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
8
97
0.82
0.13
1.0
1.1
—
55.7
—
0
9
(3017446) Testosterone [Moles/volume] in Serum or Plasma
81
776
1.05
0.12
2.8
2.2
nmol/l
12.1
12.8
0.36
72
680
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
31
332
0.93
0.11
1.3
1.4
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
31
331
0.94
0.10
1.2
1.2
—
—
—
0
0
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
312
3168
0.98
0.10
4.5
4.4
%
21.6
21.7
0.07
162
1590
(3035880) pH of Pleural fluid
10
87
1.15
0.09
1.4
1.4
—
—
—
0
0
(43055089) Myosin Ab [Presence] in Serum or Plasma by Immunoblot
5
47
1.06
0.09
1.6
1.1
—
—
—
0
0
(3052649) Adenosine deaminase [Enzymatic activity/volume] in Serum or Plasma
11
97
1.14
0.09
1.2
1.4
u/l
11.5
14.0
0.67
11
90
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
5
65
0.77
0.08
1.0
1.6
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
5
65
0.77
0.08
1.0
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
7
68
1.03
0.07
3.3
1.5
—
—
—
0
0
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
7
68
1.03
0.07
3.3
1.5
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
7
68
1.03
0.07
3.3
1.5
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
7
68
1.03
0.07
3.3
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
14
153
0.91
0.07
1.6
1.4
e6/l
32278.8
100709.0
—
8
98
(3043238) Trisomy 21 risk [Likelihood] in Fetus
11
122
0.90
0.07
1.5
1.5
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
8
93
0.86
0.06
1.3
1.7
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
19
177
1.07
0.06
1.0
1.1
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
12
110
1.09
0.05
1.2
1.3
—
—
—
0
0
(3047352) Trisomy 18 risk [Likelihood] in Fetus
11
120
0.92
0.05
1.5
1.4
—
—
—
0
0
(3033705) Calcium.ionized [Moles/volume] in Venous blood
19
179
1.06
0.05
2.1
2.5
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
14
150
0.93
0.04
1.1
1.1
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
14
150
0.93
0.04
1.5
1.6
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
11
119
0.92
0.04
1.5
1.4
—
—
—
0
0
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
14
131
1.07
0.03
1.0
1.1
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
14
149
0.94
0.03
1.4
1.6
%
52.6
63.2
—
8
92
(3003740) Influenza virus B Ag [Presence] in Specimen
14
149
0.94
0.03
1.1
1.1
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
15
142
1.06
0.02
1.4
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
15
142
1.06
0.02
1.4
1.4
—
—
—
0
0
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
32
329
0.97
0.02
1.7
1.7
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
15
143
1.05
0.01
1.4
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
15
143
1.05
0.01
1.4
1.4
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
15
144
1.04
0.00
1.7
1.4
—
—
—
0
0
(3012441) Differential panel - Pleural fluid
15
146
1.03
0.00
1.5
1.5
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
18
176
1.02
0.00
1.6
1.4
e6/l
1323.8
1748.8
0.29
12
130
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
11
108
1.02
0.00
1.0
1.1
—
—
—
0
0
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
79
794
0.99
0.00
1.3
1.4
—
—
—
0
0
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
10
97
1.03
0.00
1.4
1.2
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
30
295
1.02
0.00
1.8
1.7
e6/l
11664.9
18371.1
0.49
19
216
(3022756) Ceruloplasmin [Mass/volume] in Serum or Plasma
10
95
1.05
0.00
1.0
1.0
mg/l
316.7
284.2
—
10
81
(3025549) Creatine [Moles/time] in 24 hour Urine
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3007858) Lactate dehydrogenase 3/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.1
—
21.0
—
0
8
(3020123) Porphyrins [Interpretation] in Serum or Plasma
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
8
87
0.92
0.00
1.0
1.1
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3024830) Lactate dehydrogenase 4/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.1
—
8.3
—
0
8
(3032868) Hemoglobin electrophoresis panel in Blood
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(36659890) Mycobacterial identification panel - Specimen by Molecular genetics method
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3023919) Lactate dehydrogenase 2/Lactate dehydrogenase.total in Serum or Plasma by Electrophoresis
0
8
0.00
0.00
0.0
1.1
—
38.8
—
0
8
(3007463) Buprenorphine [Presence] in Urine
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
5
52
0.96
0.00
1.4
1.3
mmol/l
6.1
6.4
—
5
52
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3009347) Lactate dehydrogenase isoenzymes [Interpretation] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3010937) Rubella virus Ab [Presence] in Serum
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042391) t(9;22)(q34.1;q11)(ABL1,BCR) e1a2 fusion transcript/control transcript [# Ratio] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
5.8
—
—
—
0
0
(3034092) Cytoplasmic Ig cells/100 cells in Blood
0
7
0.00
0.00
0.0
5.7
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(3038026) Centromere Ab [Units/volume] in Serum
9
98
0.92
0.00
1.0
1.1
—
88.8
—
0
5
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
6
68
0.88
0.00
1.0
1.1
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.7
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(1176173) BK virus + JC virus DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
6.4
—
—
—
0
0
(1002102) Choriogonadotropin.intact+Beta subunit [Mass/volume] in Serum or Plasma
7
70
1.00
0.00
1.7
1.5
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021073) Hepatitis C virus genotype in Serum or Plasma by Sequencing
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3019298) Eosinophils/100 leukocytes in Peritoneal fluid
0
6
0.00
0.00
0.0
1.3
—
0.4
—
0
6
(40760871) Heparin induced platelet Ab [Presence] in Serum or Plasma by Immunoassay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3036525) Urea [Moles/time] in 24 hour Urine
0
7
0.00
0.00
0.0
4.7
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
6
0.00
0.00
0.0
1.0
—
2.2
—
0
6
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3007625) Streptococcus pneumoniae Ag [Presence] in Specimen
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3017312) HC gene rearrangements [Presence] in Blood or Tissue by Molecular genetics method
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
6
59
1.02
0.00
1.0
1.1
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
5
0.00
0.00
0.0
2.0
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
8
88
0.91
0.00
1.0
1.1
—
—
—
0
0
(40763091) Bacteria identified in Peritoneal dialysis fluid by Culture
0
5
0.00
0.00
0.0
3.6
—
—
—
0
0
(3038864) risperiDONE [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
14.3
—
0
7
(3012989) Citrate [Moles/time] in 24 hour Urine
0
5
0.00
0.00
0.0
1.6
—
2.3
—
0
5
(44806420)
5
54
0.93
0.00
2.4
2.4
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
15
150
1.00
0.00
1.4
1.5
—
—
—
0
0
(3041184) Isoniazid [Presence] in Urine
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(40763480) Human metapneumovirus Ag [Presence] in Specimen
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40761545) Erythrocytes.dysmorphic [Presence] in Urine sediment by Light microscopy
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0

Mortality – FinRegistry

↥

Association

Association between endpoint K11_OTHABDHER and mortality.

Females

Parameter HR [95% CI] p-value
K11_OTHABDHER 1.483 [1.31, 1.68] < 0.001
Birth year 0.992 [0.98, 1.0] 0.067

During the follow-up period (1.1.1998 — 31.12.2019), 986 out of 3918 females with K11_OTHABDHER died.

Males

Parameter HR [95% CI] p-value
K11_OTHABDHER 1.544 [1.35, 1.77] < 0.001
Birth year 0.983 [0.97, 0.99] < 0.001

During the follow-up period (1.1.1998 — 31.12.2019), 858 out of 3018 males with K11_OTHABDHER died.

Mortality risk

Mortality risk for people of age

years, who have K11_OTHABDHER.

N-year risk Females Males
1 0.122% 0.25%
5 0.813% 1.527%
10 2.132% 3.895%
15 3.966% 7.384%
20 6.631% 12.183%

Relationships between endpoints

↥

Index endpoint: K11_OTHABDHER – Other and unspecified abdominal hernia

GWS hits: 1

Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
Extremity
rg [CI]
Extremity
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
loading spinner Loading data